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ABSTRACT 
The Human Immunodeficiency Virus (HIV) has been found to cause muscle weakness, wasting 
and peripheral neuropathies. The specific relationship between lower limb muscle strength and 
lower limb function in HIV positive patients on Highly Active Antiretroviral Therapy (HAART) has 
not been examined. The aims of the current study were to establish lower limb muscle strength in 
HIV positive patients on HAART, establish lower limb muscle strength in HIV negative people, 
compare lower limb muscle strength between patients who are HIV positive on HAART and HIV 
negative people, establish lower limb function in patients who are HIV positive on HAART and to 
establish the relationship between lower limb muscle strength and lower limb function in patients 
who are HIV positive on HAART. 
A cross-sectional, descriptive study design was used. Dynamometry was used to measure lower 
limb muscle strength. The lower Extremity Functional Scale (LEFS) was used to determine lower 
limb function. A pilot study was done to establish the feasibility and proficiency required to perform 
hand held dynamometry. Intra and inter-rater reliability were also determined during the pilot 
phase. 
Intra and inter-rater reliability were high for the raters' measurement of lower limb muscle strength 
using a dynamometer with 'r' values of 0.97. For HIV positive patients on HAART, 19% (n=22) 
were in the age band 45-49years, whereas 33% (n=10) of HIV negative subjects were in age 
interval 25-29 years. Those over 45 years who were HIV positive on HAART constituted 57% 
(n=64) of the sample. 
The mean muscle strength obtained ranged from 9.30kg/m2 in ankle dorsiflexors to 15.80kg/m2 in 
hip extensors in HIV positive people on HAART for an average of 4 years while knee flexors 
generated 11.81 kg/m2 and knee extensors generated 15.36kg/m2 in this cohort.Jn the HIV negative 
matched group, the mean muscle strength ranged from 11.20 kg/m 2 in ankle dorsiflexors to 17.70 
kg/m2 in hip extensors while knee flexors generated 12.65kg/m2 and knee extensors generated 
17.07kg/m2. 
The majority 78% (n=88) of HIV positive patients on HAART had no difficulty with lower limb 
function while 22% (n=17) had difficulty. Only 2% (n=2) of HIV positive patients on HAART had 
quite a bit of difficulty with lower limb functional activities after measurements using the Lower 
Extremity Functional scale (LEFS). 
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A multiple linear regression showed that there was a positive correlation coefficient of r=0.71 (p-
value=O.OO) between lower limb muscle strength and lower limb function. The coefficient of 
determination 0.50 means that 50% of the changes in lower limb function are attributable to lower 
limb muscle strength. Gender, employment status and mode of transport also positively affected 
lower limb function. 
A detailed regression model showed that lower limb ankle plantar flexors contributed the most to 
lower limb function in this cohort. This is contrary to International literature which states that hip 
and trunk muscles are the most active in HIV negative people during lower limb functional 
activities. That plantar flexors contribute the most in lower limb functional activities instead of hip 
and trunk muscles confirms the existence of proximal weakness in this cohort which was 
established by other researchers. 
This study highlighted that 50% of lower limb function is a result of lower limb muscle strength in 
HIV positive people on HAART attending an outpatient clinic in Mutare, Zimbabwe. Ankle plantar 
flexors instead of hip flexors were the most active muscle group in lower limb functional activities in 
this cohort. It therefore means exercise prescription to activate/strengthen hip flexors and other 
proximal muscles will improve this population's lower limb functional activities since progressive 
resisted aerobic exercises have been proved to strengthen muscles. 
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CHAPTER 1 
1. INTRODUCTION 
This study is to determine if there is a relationship between lower limb muscle strength and 
lower limb function in HIV positive patients on HAART in Manicaland, a province in eastern 
Zimbabwe. Studies have shown that HIV generally cause muscle weakness (Myezwa et aI., 
2009).This is possibly due to effects of HIV disease or HAART on tissue oxygen extraction 
and utilisation (Carnethon et aI., 2005).The use of HAART in HIV treatment has been 
related to lipodysthophic alterations like lipoatrophy, mitochondrial toxicity and reduction of 
the activity of oxidative enzymes (Cade et aI., 2003). Thus, HIV and HAART negatively 
influence oxygen kinetics, limiting the extractionl use of oxygen in lower limb musculature 
(Cade et aI., 2003). Lower oxygen use capacity directly affects physical fitness and 
consequently, the individual'S motivation to perform routine activities (Mendes et aI., 2013). 
The acute phase of HIV/AIDS is thus frequently marked by a substantial loss of physical 
fitness (Raso et aI., 2013). 
HIV infected populations have impairments, activity limitations, and participation 
restrictions (WHO, 2001). Limitations in functional abilities are known to exist in HIV 
positive patients in Manicaland (Lopman et aI., 2007), however the specific effect of HIV on 
lower limb function is not known. 
Human Immunodeficiency Virus (HIV) disease is now described as an episodic condition 
that is chronic in nature (O'Brien et aI., 2009). As with other chronic conditions, 
rehabilitation has become an important part of the management of HIV impairments 
(Myezwa et aI., 2009). Understanding the impairment's functional limitations, and 
participation restrictions associated with HIV should be a pre-requisite to rehabilitation 
intervention (Myezwa et aI., 2009). 
Activities of Daily Living (ADL) capacity is preserved in more than 90% of the HIV infected 
patients on treatment with anti-retroviral medication or HAART _but these patients remain 
limited in rigorous activities such as heavy work ,walking uphill and exercises(Oursler et 
aI., 2009). Kressy et al (2009) established that all HIV positive patients including those on 
antiretroviral therapy can develop wasting. In patients with HIV infection, wasting, 
particularly loss of metabolic active lean tissue has been associated with increased 
mortality, accelerated disease progression, loss of muscle protein mass and impairment of 
strength and functional state (Grinspoon et aI., 2003).Kinsey (2007) however found no 
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significant difference in lower limb muscle strength between HIV positive females on 
HAART for seven months and their HIV negative counterparts. 
Muscles maintain their mass and function because of a balance between protein synthesis 
and protein degradation associated with equal rates of anabolic and catabolic processes 
respectively (Lynch et aL, 2007). Muscles grow when protein synthesis exceeds protein 
degradation (Lynch et aL, 2007). HIV induces muscle fibers to differentiate between self 
and non-self cells, triggering cell mediated muscle fiber injury leading to wasting (Goletz et 
aL, 1997). 
Apoptosis is key in cell production and tissue homeostasis; it purges unnecessary, aged or 
damaged cells (Miro et aL, 2005). Abnormal resistance to apoptotic cell death is the basis 
of developmental malformations, autoimmune disease and many cancers whereas 
enhanced susceptibility of cells to apoptotic signals participates in tissue damage 
secondary to acute infections (Miro et aL, 2005). Apoptosis is thus linked to the 
pathogenesis of HIV in that, increased apoptosis of CD4 T cells result in there depletion by 
HIV's use of CD4 as a primary receptor (Cloyd et aL, 2001). 
The causes of weight loss and tissue wasting in HIV patients/individuals are multiple and 
include hypogonadism, malnutrition, anorexia, infection and perhaps an HIV induced hyper 
metabolic state (Grinspoon et aL, 2010). Wasting has been found to result in decreased 
lower limb muscle strength or compromised balance in 30% of HIV positive individuals 
causing low muscle mass in legs and gluteal muscles (Carter et aI., 2011). Each year of 
infection with HIV was also found to increase the risk of poor lower limb performance by 8% 
(Carter et aL, 2011). Therefore HIV has the potential to decrease the physical activity 
levels and functional independence of infected individuals (Kinsey, 2007). 
HIV has distinct multifaceted physiological, emotional and societal features at any stage of 
the disease with the possibility of losing functional capacity and affecting Health Related 
Quality Of Life (HRQOL) (Van As et aL, 2008). Studies on quality of life in HIV positive Sub-
Saharan patients are however limited (Mutimura et aL, 2007). Sterne et al (2005) found that 
HAART is becoming more accessible to HIV-infected people in resource limited regions of 
the world and their quality of life is also improving. HIV affects function in general and more 
specifically one study has shown that proximal weakness is a common feature when HIV 
patients were tested using dynamometry (Myezwa et aL, 2009). In another study one of two 
adults with undetectable viral load, which is HIV RNA of less than 50copies/ml (controlled 
HIV) had poor lower limb muscle performance, which put this population at risk of falls and 
3 
fracture (Richert et aL, 2011) hence assessment of lower limb strength should be carried 
out as part of routine HIV care (Carter et aL, 2011). Aerobic and progressive strengthening 
exercises can then be prescribed since these exercises have been associated with 
improvements in muscle strength, activities of daily living, cardiovascular function and 
psychological status in general populations (O'Brien et aL, 2009). Exercises may also be 
used to address unwanted changes in weight and body composition in people living with 
HIV infection (O'Brien et aL, 2009). 
1.1 PROBLEM STATEMENT 
There is not much research done on the relationship between lower limb muscle strength 
and lower limb function in HIV positive patients on HMRT in Manicaland, Zimbabwe.HIV 
has been found to cause muscle weakness, wasting and peripheral neuropathies (Van As 
et aL, 2008). The specific relationship between lower limb muscle strength and lower limb 
function in HIV positive patients on HMRT has however not been pursued in Manicaland, 
Zimbabwe. Establishing lower limb muscle strength in HIV positive patients on HMRT 
provide empirical data that is currently limited. Furthermore, there is need to establish 
whether there is a relationship between lower limb muscle strength and lower limb function 
in order to design interventions that can counteract a decrease in lower limb function as 
well as the impact on specific related function such as core stability. It might also influence 
policy changes and plans to support provisions of rehabilitation services. 
1.2 RESEARCH QUESTION 
What is the relationship between lower limb muscle strength and lower limb function in HIV 
positive patients on HMRT? 
1.3 OVERALL AIM OF THE STUDY 
The aim of this study is to establish the relationship between lower limb muscle strength 
and lower limb function in patients who are HIV positive on HMRT. 
1.4 STUDY OBJECTIVES 
1. To establish lower limb muscle strength in patients who are HIV positive on HMRT. 
2. To establish lower limb muscle strength in HIV negative patients. 
3. To compare lower limb muscle strength between patients who are HIV positive on 
HMRT and HIV negative people 
4. To establish lower limb function in patients who are HIV positive on HMRT 
5. To establish the relationship between lower limb muscle strength and lower limb 
function in patients who are HIV positive on HMRT. 
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1.5 SIGNIFICANCE OF THE STUDY 
This study may contribute to understanding the extent and level of muscle strength and its 
relationship to lower limb function in adults with HIV infection on HAART. The effect of 
muscle weakness on specific functions such as sit to stand and balance in standing will 
help with designing interventions for countering reduction in lower limb function as well as 
the impact on specific related functions such as core stability where common muscles that 
have dual function in the lower limbs such as psoas, transverse abdominis and rectus 
abdominis maybe indirectly affected. 
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CHAPTER 2 
2. LITERATURE REVIEW 
2.1 INTRODUCTION 
Before looking on the effect of HIV on lower limb function and lower limb muscles, a brief 
review of what HIV is and how big the problem is in Zimbabwe is undertaken. The disease 
history in Zimbabwe, that is the prevalence, behavior, how bad was the problem, when did 
it peak and where it is now will be discussed. The study will also discuss the infection and 
effects of HIV and HAART on the human body and its specific effects on lower limb muscle 
strength, together with the impact of HIV on people as they age. A review of the literature 
on how HIV and HAART affects lower limb function focusing on its effects related to the 
skeletal system and Health Related Quality of Life (HRQOL) will be done. Interventions to 
reduce the HIV effects on lower limb muscle strength, lower limb function and HRQOL will 
also be examined. Methods to establish lower limb muscle strength and lower limb function 
will be reviewed, highlighting the reasons why these methods were chosen for use in this 
study. 
2.2 METHODOLOGY OF LITERATURE REVIEW 
Specific research portals were accessed to search for articles related to the topic of interest 
e.g. publications, Pub med, Cochrane reviews and Google Scholar. Specific websites were 
accessed for further explanatory information e.g. Google, World Health Organization 
(WHO), United Nations program on HIV/AIDs (UNAIDS), United Nations General Assembly 
(UNGASS) and the National Aids Council (NAC) of Zimbabwe. In addition, the following 
processes were conducted to gather information relevant to the project: specific research 
publications, articles, texts and congress presentations were reviewed. 
2.3 HISTORY OF HIV IN ZIMBABABWE 
HIV prevalence in Zimbabwe in the adult population (15-49 years) was 20% in 2005 down 
from 22% in 2003 (Lopman et aI., 2007). It further dropped to 14% in 2009 (UNAIDS, 2009) 
then rose to 15% in 2013 (NAC, 2013). 
The emergence of HIV-1 resulted from the cross-species transmission of simian 
immunodeficiency virus from Chimpanzees to humans in West-Central Africa at the 
beginning of the 20thcentury (Worobey et aI., 2008). Group M, responsible for the vast 
majority of HIV infections worldwide, initially spread throughout Africa. In response to 
actions of several genetic forces, the HI virus has diversified into different subtypes (Sharp 
6 
et aL, 2010).The spread of these variants in the human population was not noticed for 
nearly eight decades (Jungueira et aL, 2011). The first records of infection date back 
t01981 in American patients infected with subtype B virus. These patients presented with 
clinical symptoms which is known today as AIDS (Gallo et aL, 1983, Barre-Sinoussi et aL, 
1983). 
In Zimbabwe, the first cases of HIV/AIDS were identified in the mid-1980s (UNAIDS, 2008). 
By 1990 (the first year of Antenatal Clinic (ANC) based surveillance) HIV prevalence 
exceeded 10% (Gregson et aL, 2010). According to the United Nations General Assembly 
(UNGASS) report in December 2007 on HIV and AIDS in Zimbabwe, HIV prevalence was 
at its peak in 2001 with an estimated prevalence of 27%.The prevalence declined to 23% in 
2003, further declining t019% in 2005 and 15% in 2007 (UNGASS,2007). 
The National Aids Council (NAC) of Zimbabwe (2013) reported an HIV prevalence of 14% 
in 2012 in Zimbabwe. The prevalence rose to 15% in 2013. In the June 2013 NAC report, 
Zimbabwe's three Southern provinces of Bulawayo, Matabeleland North and South 
recorded the highest HIV figures. Bulawayo had 19% while Matabeleland North and South 
had 21 % each. Harare province reported a prevalence of 13%. Other provinces; 
Mashonaland central, Masvingo, and Manicaland had 14% each. NAC attributed the high 
Matabeleland figures to spousal separation. The spousal separation was as a result of 
people crossing the border to neighbouring countries such as Botswana and South Africa in 
search of jobs. Gregson et al (2001) however observed that the HIV epidemic in Zimbabwe 
initially affected more mobile and more educated men. This was because of the men's 
ability to attract sexual partners irrespective of their geographical location. As early as 1998 
risk was similar or perhaps slightly lower for those with secondary education (Gregson et 
aL, 2001).Mbizvo et al (1997) and Machekano et al (1998) found that in Zimbabwe, most 
incidence estimates were not from population based studies. It therefore means that the 
June 2013 NAC finding could have been biased. Lopman et al(2008) noted that in virtually 
all settings where there is a generalized HIV epidemic in Zimbabwe, there is no reliable 
surveillance systems to monitor new AIDS cases. This poor surveillance is prevalent in 
most Southern African countries, vital registration systems are unreliable because of 
substantial underreporting (Feeney, 2001). Hospital records can also be biased, especially 
in rural areas, since many people die at home and AIDS deaths could be underreported to 
protect surviving kin from stigma (WHO, 2004).Therefore the June 2013 NAC report might 
be inaccurate (Feeney, 2001). 
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2.4 HIV INFECTION AND EFFECTS ON HUMAN BODY 
HIV carries its genetic information in the form of RNA (Brenchley et aI., 2008). When the 
virus enters the cell, the RNA is reverse transcribed to DNA. An enzyme called Reverse 
Transcriptase (RT) reverses the normal transcription process so that a DNA copy is made 
of the viral RNA genome. This new copy called a provirus is then integrated into the cell 
genome of the original DNA (Anderson, 2006). After a period of latency, the replicated 
virons bud out of this lymphocyte and infect other lymphocytes. Many virons are released 
per day. They continually infect and destroy additional T-Iymphocytes leading to 
immunosupression (Anderson, 2006). 
Immunosuppression leaves the individual susceptible to a wide variety of conditions and 
malignancies which are collectively called opportunistic conditions (Anderson 2006). 
Among the opportunistic conditions are musculoskeletal effects. They are as a result of 
muscle derangements due to HIV infection (Otis et aI., 2008). Musculoskeletal effects may 
include polymyositis, rhabdomyolysis, tumor infiltrations, wasting syndromes, severe lower 
limb weakness and a general feeling of tiredness that does not really go away even after 
resting (Otis et aI., 2008).ln the general population, osteoporosis and fractures are common 
in people infected with HIV (Cotter et aI., 2013). The risk of fractures is almost two fold in 
people living with HIV on HAART compared to the general population (Carter, 2011). HIV 
positive people experience mobility challenges and a decreased quality of life as a result of 
frailty secondary to muscle weakness (Cotter et aI., 2013). 
2.5 HIV SPECIFIC EFFECTS ON MUSCLE 
Lower limb muscle weakness is a common complaint among HIV positive patients 
presenting to family physicians (Sagui, 2005). Although the cause of weakness is 
occasionally apparent, there are many cases where it is unclear. Therefore comprehensive 
evaluation of HIV positive patients is necessary. A thorough examination should be 
coordinated with appropriate laboratory, radiological, electro - diagnostic and pathological 
studies to identify the exact cause of muscle weakness (Sagui, 2005). 
Mascolini (2011) suggested that weakness occurred as a result of the HIV virus' 
interference with oxygen extraction or use. Cade et al (2003) noted that muscle oxygen 
extraction and utilisation limitation is a mediator of diminished aerobic capacity in 
individuals who are infected with HIV on HAART. HAART medication disrupts normal 
mitochondrial function. This limits muscle oxygen extraction-utilisation in most individuals 
treated for HIV infection (Cade et aI., 2003). These alterations in mitochondrial function 
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deplete oxygen utilisation in lower limb muscles causing lower limb muscle weakness even 
when oxygen delivery is unaffected (Cade et aL, 2004). 
Apart from mitochondrial toxicity in lower limb muscles, HIV is also associated with 
metabolic disorders causing morphological alterations. Morphological alterations include 
loss of peripheral subcutaneous fat (Iipoatrophy), accumulation of central visceral (intra-
abdominal) fat and fat in the dorsal cervical thoracic region (lipohypertorophy) (Garg, 2011). 
Furthermore morphological alterations together with pain often slow an individual's activity 
levels resulting in reduced functional activity tolerance and quality of life (Kietrys et aL, 
2014). 
HIV-associated lipodystrophy is associated with HAART regimes that include nucleoside 
reverse transcriptase inhibitors although other mechanisms maybe involved (Kietrys et aL, 
2014).Secondary to co-morbidities associated with HIV disease, HAART in some 
individuals, offer benefits at the cost of debilitating side effects (Bopp et aL, 2003). There is 
loss of lean body mass (LBM) with relative maintenance of total body mass (Mendes et aL, 
2013).These alterations are associated with reduction in capacity to generate lower limb 
muscle strength and limitation of functional status (Mendes et aL, 2013). The mechanism 
as reviewed above is related to lipodystophic alterations like lipoatrophy (Dellisola et aL, 
2004), mitochondrial toxicity (Kohler et aL, 2007) and the activity of oxidative enzymes 
(Cade et aL, 2003). 
Therefore HIV and HAART negatively influence oxygen usage, limiting the extraction/use of 
oxygen in the lower limb musculature (Mendes et aL, 2013). Lower oxygen use capacity 
directly affects physical fitness, and consequently, the individual's motivation to perform 
routine activities (Mendes et aL, 2013). 
HIV can deprive an individual of his or her physical resources such as mobility, lower limb 
muscular strength, joint flexibility, endurance and energy (Clingerman, 2003). There is a 
high prevalence of fatigue and lack of endurance in HIV positive patients, many of whom 
face challenges with daily functional activities (Rusch et aL, 2004). This is exacerbated by a 
compromised pulmonary function with resultant lower limb muscle weakness and 
compromised lower limb function (Pothott et aL, 1994). 
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2.6 HIV AND HAART'S EFFECTS ON FUNCTION AND HEALTH RELATED QUALITY OF 
LIFE (HRQOL) 
HI virus has complex effects on the body and can impact the functioning of individuals in 
everyday life (Myezwa et aI., 2011). The disease complexity and potential side effects of 
HAART make successful disease management a challenge for many individuals (Kietrys et 
aI., 2014). People living with HIV/AIDS on HAART are concerned with the quality of life they 
are able to lead over and above a treatment's ability to extend life (Gale, 2003). South 
Africans living with HIV/AIDS' quality of life and elsewhere has been found to be severely 
compromised (Myezwa et aI., 2011). 
Increased longevity in HAART era has been mirrored by an increase in co-morbidities and 
episodic disability experienced by some individuals (Cade et aI., 2010). Disability 
associated with HIV disease can be worsened or relieved by extrinsic factors such as 
coping strategies and lifestyle choices (O'Brien et aI., 2009). Performance-based measures 
aimed at the upper end of the functional spectrum among middle-aged and older adults 
with HIV infection identified greater than expected impairments in walking speed, balance, 
peak exercise capacity, and ability to rise from a chair (Erlandson et aI., 2013). 
Evidence is there that HIV can replicate in compartments different from plasma (Kashuba et 
al.,1999) such as the brain thereby establishing viral sanctuaries. Antiretrovirals have 
limited penetration into these viral sanctuaries where viral replication continues during 
treatment leading to resistant HIV strains (Saksena et aI., 2003). There is resultant brain 
damage in HIV-positive patients on HAART even though there viral load was suppressed 
by anti-retroviral therapy. The brain damage decreased lower limb function. This means 
anti-viral medications might not stop brain damage even among those who are virally 
suppressed (Perper et aI., 2006). 
Symptoms of HIV brain damage include depression, memory loss, a slowing of mental 
response time and sluggishness in lower limb movements. These symptoms can progress 
to HIV dementia. HIV dementia is a neurological damage that used to affect 20% of HIV 
patients prior to the advent of antiretroviral therapy (Perper et aI., 2006). 
Research conducted in 2002 showed that 30% of HIV-positive individuals had problems 
with lower limb muscle strength or balance (Carter, 2011). Investigators from the French 
Agency of AIDS and Hepatitis Research (ANRS) C03 Aquitaine cohort wished to gain a 
better understanding of Locomotor performance in HIV positive patients in the modern 
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treatment era of HAART. Locomotor function was assessed using validated tests which 
include 1- overall balance, 2- distance walked in six minutes at an accelerated speed, 3-
time to stand up from an armchair, walk three meters, turn around, walk back to chair and 
sit down, 4- five times sit-to-stand test and 5- time needed to stand up from a sitting 
position five times. (Carter, 2011).These patients had been living with HIV for a long time 
with 83% of them on HAART. Results showed the majority of the patients had poor lower 
limb function (Carter, 2011). 
More than half of HIV positive people in a French Aquitaine cohort had poor leg muscle 
strength with compromised lower limb function when compared to the general population 
(Mascolini, 2011). Poor lower limb muscle performance put this population at risk of falls 
and fractures" (Mascolini, 2011).ln a cross-sectional survey done in 2002, data suggested 
that up to 30% of HIV infected patients had complaints with Locomotor function and 
balance (Rusch et aL, 2004). Antiretroviral drugs, (didanosine, stavudine, zalcitabine and 
zidovidine) decreased locomotor performance in the early HAART era through a pathway of 
peripheral neurotoxicity (Scruggs et aL, 2008) and adverse effects on the muscle by 
mitochondrial toxicity which disrupt lower limb muscle structure and function (Bauer et aL, 
2011). In addition, HAART treatment has been associated with distal sensory neuropathies 
that affect proprioception and coordination of movement in the lower limbs (Bauer et aL, 
2011 ). 
HAART treatment though associated with distal sensory neuropathies is now easily 
accessible, leading to a shift in HAART experiences in hyper-endemic countries. The 
international classification of Function (ICF) offers a framework for considering the 
experience of HIV in the era of enhanced access to HAART in South Africa (Hanass-
Hancock et aL, 2013). The ICF classifies impairments, activity limitations, participation 
restrictions and the environment as components that all playa role in disability. The ICF is 
regarded as the most comprehensive model available for describing and understanding 
disability and function; it is a complex instrument intended to cover all aspects of human 
functioning (Myezwa et aL, 2011). 
2.7 IMPACT OF HIV ON MUSCLE STRENGTH AS PEOPLE AGE 
HIV is now a chronic disease associated with longevity accompanied by a diverse range of 
health related challenges like lower limb muscle weakness (Hanass-Hancock et aL, 
2003).Age associated skeletal muscle sarcopenia is generally characterized by reduced 
muscle mass and strength. It is manifested by preferential type 11 myofibre atrophy, 
myofibre necrosis and increased intramuscular content of non-muscle (Le. adipose and 
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connective) tissues (Hunter et aI., 2004). Preferential type 11b myofibre atrophy partly 
accounts for loss of lower limb muscle strength with age. The decreased muscle strength is 
a result of impaired excitation-contraction coupling as calcium release decline with age 
(Cade et aI., 2003) 
As people get older, myofibres will change from 1, 11 a and 11 bfiber types. This is because 
a different axon type from the heterogeneous fiber distribution pattern normally found in 
younger muscle now enervates older muscle thereby changing the fibre type(Hunter et aI., 
2004). Changes in muscle fibre type lead to a decrease in muscle strength because of 
muscle shrinkage and loss of muscle fibers. Under normal conditions, muscle strength in 
women and men reaches its peak between the ages of twenty and thirty years. Muscle 
strength then remains virtually unchanged for another twenty years, if there is no disease or 
injury (Humphries, 2008). Muscular performance after this point deteriorates at a rate of five 
percent per decade. This amounts to a loss of thirty to forty percent of muscle strength over 
the adult life span. Variations in the rate of loss reflect the diversity of occupations, physical 
activity backgrounds, muscles used and type of muscle contractions (Humphries, 2008). 
Decline in skeletal muscle size and alterations in neural function, such as loss of motor 
neurons, decreased maximal motor unit firing rates and impaired neuromuscular activation 
(Clark et al.,2012) contributes to reduced lower limb muscle strength in older adults 
(Doherty, 2003). As a result of these changes, there is selective atrophy and loss of type 
11 a fibers which have the ability to generate 4-6 times more power than type 1 fibers, 
compromising successful development of dynamic muscle strength during lower limb 
functional activities (Reid et aI., 2013).Also higher accumulation of intramuscular adipose 
tissue has been linked with an inability to fully activate muscles during dynamic contractions 
in lower limb functional activities (Yoshida et aI., 2012). 
Elderly people when sedentary for a long time experience decrease in muscle strength, 
compromising their quality of life. HIV/AIDS worsen this situation since HIV decrease 
muscle strength and function (Souza et aI., 2011).Medications, infections (such as HIV 
infection) and neurological disorders commonly cause lower limb muscle weakness (Roos, 
2003). Lower limb muscle power is a determinant of falls, which accelerates disability and 
mortality (Moreland et aI., 2004). 
Lower limb muscle strength decrease with age faster in HIV infected individuals compared 
to HIV negative people, resulting in impairment of Locomotor function, deterioration of 
functional ability and limitations in activities of daily living (Richert et aI., 2011). These 
muscular impairments are also associated with daily activity limitations and participation 
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restriction (Rusch et aI., 2004). The most common motor impairments in AIDS patients on 
HAART are slowed movements, gait abnormality, limb inco-ordination, hyper-reflexia, 
hypertonia and muscular weakness (Bernard et aI., 2013). 
Loss of skeletal muscle mass has a significant impact on functional performance, 
independent function and associated quality of life in HIV patients. HAART became the 
standard of care for HIV intervention in 1995 and the incidence of wasting (involuntary 
weight loss more than 10% ideal body weight) has declined although it is common (Scott et 
aI., 2007). In the era of HAART, recent work indicates that HIV associated weight loss is 
primarily due to fat atrophy, which accounts for approximately two-thirds of the weight loss 
while loss of lean body mass accounts for the other third (Grinspoon et aI., 2003). Given the 
wide ranging physiological consequences of HIV infection and HAART, mechanisms 
beyond reduction in muscle mass are likely contributors to impaired function (Estanislao et 
al.,2004). 
Half of American adults with controlled HIV infection had poor lower limb muscle strength 
as assessed through the five-sit-to-stand test (5-STS) (Bernard et aI., 2013). HIV patients 
on HAART present with white matter alterations (Chen et aI., 2009), psychomotor slowing 
and postural instability (Sullivan et aI., 2011). Chronic infection with HIV has been 
associated with skeletal muscle impairment which is related to deterioration of functional 
ability in activities of daily living (Scott et aI., 2007). Lower limb muscle weakness is known 
in the disease process, but its relationship to central motor command integrity has not been 
investigated to date (Bernard et aI., 2013). 
Poor lower limb muscle performance and balance disorders predict the risk of falls and 
disability in HIV positive people on HAART and elderly community dwelling individuals of 
the general population (Bliuc et aI., 2009). Furthermore, low quadriceps strength is an 
independent risk factor for hip fracture and a predictor for mortality and fragility fracture 
(Bliuc et aI., 2009). The association between reduced lower extremity strength, poor 
mobility and functional dependence in HIV positive people on HAART and frail elders are 
well known (Wang et aI., 2009). Fortunately, muscle does not lose its ability to respond to 
training even in older persons or HIV positive people on HAART (Wang et aI., 2009). Older 
persons and HIV positive people on HAART's functional mobility performance and 
independence can be improved by enhancing lower limb muscle function (Wang et aI., 
2009). 
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2.8 INTERVENTIONS TO REDUCE HIV/HAART EFFECTS ON LOWER LIMB FUNCTION 
AND HRQOL 
Physiotherapy has been shown to improve lower limb functional activities and quality of life 
in HIV patients on HAART(Javier et aI., 2011; Lopez-Sendin et al.,2012).Current literature 
however lacks well designed studies regarding the specific role of the physiotherapist in the 
treatment of this population (Pullen et al.,2014). The limited research available is mainly 
focused on exercise and does not examine the effectiveness of the full spectrum of skilled 
physiotherapy for treating HIV-related symptoms (Pullen et al.,2014). Given this gap in the 
literature, it is necessary to develop comprehensive physiotherapy interventions for HIV 
positive patients on HAART and to understand the comorbidities experienced by this 
population (Pullen et aI., 2014). 
World Confederation of Physical Therapy (WCPT) define physical therapy as; "providing 
services to people and populations to develop, maintain and restore maximum movement 
and functional ability throughout their life-span; therefore physiotherapists are best placed 
to design rehabilitation strategies to improve lower limb muscle strength and 
function(Kumar et aI., 2010). Physiotherapy includes the provision of services in 
circumstances where movement and function are threatened by the process of ageing or 
that of injury or disease as in HIV infection. Full and functional movement is at the heart of 
what it means to be healthy (Kumar et aI., 2010). 
As noted before, HAART has drastically improved the functional movement, prognosis and 
quality of life of patients infected with HIV on HAART. Some individuals on HAART however 
still experience neuromuscular problems due to lower limb muscle weakness (Bernard et 
aI., 2013).ldentifying the factors beyond the reduction of muscle mass that contribute to 
impaired function is required for optimizing the design of rehabilitation strategies to improve 
lower limb muscle strength and functional capacity in this chronically ill patient population 
(Scott et aI., 2007). 
Factors to survive for long with AIDS, include a positive attitude towards the illness. 
(Kendall,1992) Health promoting behaviors (Lutgendart et aI., 1994), spiritual activities 
(Nunes et aI., 1995; Kendal et aI., 1994) and socializing in groups pertaining to AIDS is also 
helpful (Kendall, 1992; Lutgendart et aI., 1994;Nunes et aI., 1995).Aerobic exercises have 
beneficial psychological and immunological effects on individuals with HIV on HAART 
(Antoni et aI., 1990; LaParriere et aI., 1991 and 1994, MacArthur et al.,1993).Effects of 
exercises on the immune system in chronic illness like HIV however remain largely 
unexplored (Smith et aI., 2007). 
14 
Progressive resistance exercise improves strength, power and endurance (Rigbsy et aI., 
1992, Spence et aI., 1990) hence better lower limb function. Additional evidence shows that 
combined aerobic and progressive resistance exercise enhances strength and endurance 
for HIV patients on HAART (Rigsby et aI., 1992; O'Brien et aI., 2004) leading to better lower 
limb functional status. Most studies which examined effects of aerobic exercises however 
used fatigue measurement scales to determine adverse effects rather than explore positive 
effects (Petajan et aI., 1996; Mostert et aI., 2002). 
Tai Chi is a form of light resistance exercise that can be performed by patients who are 
unable to participate in rigorous programmes (Galantino et aI., 2005). Tai Chi improves 
balance consequently helping prevent falls in the elderly and HIV positive people on 
HAART (Wolf et aI., 1993 and 1996). Social support is also a well-known explanation for 
high level lower limb functioning in the face of adversity (Gore, 1978; Holahan et aI., 1982). 
Individual exercises result in psychological and functional enhancement. Group exercises 
further improved such opportunities (Galantino et aI., 2005). Group exercises however 
require time tables therefore time tabled classes may exclude those who cannot travel or 
whose work or family commitments prevent attendance (Smith at aI., 2007). The 
interdependence of positive physical changes and enhanced psychological coping due to 
exercises improves HRQOL (Galantino et aI., 2005). 
There is evidence that nutritional counseling and support, appetite stimulants, progressive 
resistance training, and anabolic hormones can reverse weight loss and increase lean body 
mass thereby improving lower limb muscle strength and lower limb function in HIV infected 
patients (Grinspoon et aI., 2003). Body composition and metabolic changes can also be 
improved through resistance and aerobic exercise training programs. These exercises are 
as effective as other non-pharmacological treatments used for managing HIV-related 
complications and for improving HRQOL (Yarasheski et aI., 2001). 
Body composition and metabolic abnormalities associated with body fat redistribution, such 
as glucose, lipid abnormalities and hypertension have been reported in approximately 20-
60% of HIV positive patients receiving HAART (Carr et aI., 1999). In developing countries, 
body fat redistribution and metabolic abnormalities have been reported in HAART-treated 
HIV patients and in HIV infected Africans receiving first line WHO recommended HAART 
(Stewart, 2002). Cardio respiratory exercise training is an established, cost-effective 
exercise regime that improved cardiovascular, lower limb function and diabetic risk profile in 
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HIV positive individuals from Western countries (Stewart, 2002). Regular cardio respiratory 
exercise training has been recommended in the guidelines for management of HIV-related 
dyslipidemia and functional loss due to lower limb muscle weakness (Dube et aL, 2003). 
Furthermore in Sub-Saharan Africa, cardio respiratory exercise training can be an important 
treatment for body fat redistribution, lower limb functional loss and metabolic disorders in 
HIV positive individuals taking HAART (Mutimura et aL, 2008). Mutimura et al (2008) 
established that cardio-respiratory training exercises improve lower limb functional loss and 
body composition. In addition; there is a decrease in waist circumference, waist-to-hip ratio 
and percentage body fat mass in WHO - recommended HAART - treated HIV positive 
African subjects with body fat redistribution in Rwanda. Exercise training also reduces total 
serum cholesterol, glucose and improves cardio respiratory fitness (Mutimura et aL, 2008). 
Characteristics of body fat redistribution however are considerably disfiguring i.e. an 
individual develops a buffalo hump and loss of fat to the abdomen, breasts and face 
(Reynolds et aL, 2006). Body fat redistribution therefore compromises HIV serostatus 
privacy, producing social isolation and distress, resulting in psychological repercussions 
(Blanch et aL, 2004). HIV positive patients with body fat redistribution experienced social 
isolation and stigma because of their body image which forced disclosure of their HIV 
status (Mutimura et aL, 2008).These patients were therefore more likely not to participate in 
group cardio respiratory exercise training thereby compromising their lower limb functional 
status. Body fat redistribution also adversely influence patient's attitude towards benefits of 
HAART leading to decreased adherence to the drugs with subsequent adverse impact on 
patients' HRQOL (Ammassari et aL, 2002). 
A positive attitude towards HIV infection (Kendal, 1992), health promoting behaviors 
(Lutgendart et aL, 1994), and spiritual activities (Nunes et aL, 1995; Kendal et aL, 1994), 
combined aerobic and progressive resistive exercises enhances lower limb strength, lower 
limb function and endurance in HIV positive patients on HAART (Rigsby et aL, 1992; O'brien 
et aL, 2004). 
Current literature promotes moderate exercises as safe and beneficial for HIV positive 
people on HAART during any stage of their illness, but exhaustive exercises (exercises 
lasting more than 90 minutes) should be avoided(Anderson, 2006).Exhaustive exercises 
weakens nonspecific immunity, neutrophil activity decreases with a resultant decline in 
phagocytic defense against infection (Lawless et aL, 1995). 
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2.9 INSTRUMENTS TO ESTABLISH LOWER LIMB MUSCLE STRENGTH AND LOWER 
LIMB FUNCTION 
Lower limb muscle strength which influences lower limb function is the ability for the muscle 
to generate maximal force (Reid et aI., 2013). Muscle strength in this study refers to 
characteristics such as muscle force, rate of force development and muscle power 
(Suominen et aI., 2008). 
Muscle produces force by sliding filaments crossing each other, which is called a muscle 
contraction (Suominen et al.,2008). A muscle contraction maybe static (involving no 
movement) or dynamic (involving movement) (Suominen et aI., 2008). In static or isometric 
muscle contraction, the total length of the muscle does not change and the joint angle 
remains constant. Maximal isometric muscle force is defined as the maximum voluntary 
contraction performed at a specific joint angle against an unyielding resistance usually 
tested with a dynamometer (Suominen et aI., 2006). 
Several studies have been conducted using dynamometry. The degree to which a patient's 
lower limb muscles are impaired is established if the clinician has objective normal values 
against which to compare the patient's lower limb strength (Rothstein et aI., 1993). Manual 
muscle testing such as the oxford scale does not provide such quantitative values 
(Bohannon,1997). Dynamometry provides quantitative values, to which a patient's 
performance can be compared (Bohannon, 1997). In a study by Bohannon (1986) involving 
30 patients with a mean age of 51.9years (range 17-82 years), three dynamometer strength 
scores were taken and recorded for each muscle group tested. This was done to calculate 
test-retest reliability. The correlations calculated for the pairs of strength scores ranged 
from 0.84 to 0.99 (p-value= 0.01). This demonstrated good reliability. Hand held 
dynamometer is therefore a reliable procedure (Bohannon, 1986).ln this study we used the 
Wagner Force Dial PD440 dynamometer. The correlations calculated for the three 
measurement scores ranged from 0.76 to 0.97 (p-value= 0.01). This also demonstrated 
good reliability of this particular dynamometer. 
In the hands of a tester with adequate strength and skill, a hand held dynamometer can be 
used to measure the strength of ten or more actions on both sides of a patient's body 
(Bohannon, 1997). The hand held dynamometer incorporates a load cell and has a digital 
display and is set to read force in Newton's or Kg/m2 (Bohannon,1997). Lower limb muscle 
strength testing is done by isolating a particular muscle or muscle group, and then an 
external force is applied (Dutton, 2009) Resistance applied at the end of the tester range is 
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termed a "break test" while resistance applied throughout the range is termed a "make test" 
and the results of the strength testing differ depending on the method used (Dutton, 2009). 
The isometric hold (break test) shows the muscle to have a higher test grade than the 
resistance given throughout the range (make test) and the handheld devices used in 
dynamometry can help quantify the "breaking force" necessary to depress a limb held in a 
specific position by the patient (Dutton, 2009).Myezwa et al (2009) used dynamometry in 
HIV populations with good results. 
The Lower Extremity Functional Scale (LEFS) is used to evaluate the functional impairment 
of a patient with disorder of one or both lower extremities (Binkley et aL, 1999).lt can be 
used to monitor the patient over time, evaluate the effectiveness of intervention (since it has 
capacity to detect change in lower limb function), easy to administer and score. LEFS 
however only measures lower limb function not overall health (Binkley et aL, 1999). It is 
more interpretable with respect to understanding error associated measurement, 
determining minimally clinically important score changes. It has a sufficient measure of 
reliability, validity and sensitivity to change at a level that is commensurate with utilization 
on individual patient level (Binkley et aI., 1999). The error associated with a given measure 
on the LEFS is about ±5 scale points (r=94) indicating excellent reliability (Watson et aL, 
2004). The construct validity and responsiveness were supported by high correlations with 
prognostic scores meaning LEFS is reliable, valid and responsive for use in patients with 
lower limb musculoskeletal dysfunction (Binkley et aI., 1999). 
The instruments (hand-held dynamometer and Lower Extremity Functional Scale) were 
valid with good reliability for measuring lower limb muscle strength and lower limb function 
in HIV positive patients HAART (Bohannon, 1986; Binkley et aI., 1999) 
18 
CHAPTER 3 
3. METHODOLOGY 
3.1 INTRODUCTION 
In this chapter the research design, instruments, procedure and statistical analysis of the 
study will be presented and explained. 
3.2 STUDY DESIGN 
This is a descriptive and cross sectional study. 
3.3 STUDY SETTING 
This study was conducted at Mutare Provincial Hospital, Manicaland, Zimbabwe. 
3.4 ETHICAL CLEARANCE 
Prior to commencement of data collection, ethical clearance was obtained from University 
of the Witwatersrand Human Ethical Research Committee (Clearance Certificate Number 
M120715 - Appendix A). Ethical clearance was also obtained from the Medical Research 
Council of Zimbabwe (Approval number MRCZlB/514 - Appendix B).Permission to conduct 
the study was sought and granted from Health study office, Medical research council of 
Zimbabwe and Mutare Provincial Hospital Medical Superintend. We sought this permission 
through an application form for Medical research council (Appendix E) and application letter 
for Mutare Provincial Hospital (Appendix F).Written informed consent (Appendix C) from the 
participants was obtained before they participated in the study. Anonymity and 
confidentiality of data was ensured by coding the results ensuring no patient identification 
was given and maintained (Appendix D). Participants were informed of their results. 
3.5 PILOT STUDY 
The pilot study was done on 30 HIV negative individuals who were 18 to 70 years old in 
Mutare district to establish lower limb muscle strength in HIV negative people. We randomly 
sampled 30 HIV negative individuals who were blood donors on the National Blood 
Transfusion register who would have undergone an HIV test (this is a requirement for blood 
donors to remain on the donor list). To ascertain if the lower limb muscle strength using 
dynamometry can be judged as "strong" or "weak", reference values are required. No 
literature could be found where reference values for lower limb muscle strength in a typical 
African healthy population were presented. 
19 
The pilot study was done to test the feasibility and proficiency of using hand-held 
dynamometry for the main study. Inter and intra-rater reliability was also established during 
the pilot phase. 
3.6 STUDY POPULATION 
HIV+ people in Manicaland aged between 18 and 70 years old on HAART who were 
already enrolled in the opportunistic infection clinic, attending appointments for monthly 
check-ups on how they were coping on HAART with doctors and primary health care 
sisters. Patients attending this clinic came from urban and rural areas. 
3.7 INCLUSION CRITERIA FOR MAIN STUDY 
Male and female adult HIV positive patients, who were on HAART, 18 to 70 years old and 
were ambulant. 
3.8 EXCLUSION CRITERIA 
i. Patients who were non-ambulatory. 
ii. Pregnant at time of assessment. 
iii. Stroke patients(CVA). 
iv. Those with known muscle weakness like Chronic Inflammatory Polyneuropathy Disease 
and Gullain-Barre syndrome. 
v. Diabetic patients. 
vi. Patients suffering from alcoholism. 
vii. Patients without capacity to follow instructions and give informed consent. 
3.9 SAMPLE 
3.9.1 Sampling Frame 
Our sampling frame was the register for HIV patients on HAART kept at Mutare Provincial 
hospital. Participants were approached for permission to take part in the study as they 
came into the clinic. 
3.9.2 Sample Size 
Using statistical calculation (epi info 3.5.4), using a population size of 3500 HIV positive 
patients registered at Mutare Provincial Hospital, expected number of patients with Lower 
limb weakness being 10% (Oursler et ai, 2009) of the registered patients (3500) and worst 
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acceptable being 15% of registered patients at 95% confidence interval, a sample size of 
113 participants was calculated . 
3.9.3 Sampling 
Systematic random sampling was used where we picked every third patient who met the 
inclusion criteria as they came into the clinic (Castillo, 2009). An equal number of males 
and females were targeted. Four to six patients were taken per day until we got the sample 
size. This was done in two months to get the total sample. 
3.10 OUTCOME MEASURES 
Outcome measures (Table 3.1) was kg/m 2 for lower limb muscle and a functional lower limb 
score measured using Lower Extremity Functional Scale (LEFS). 
Table 3.1: Outcome Measures 
Objective Outcome Reliability and Procedure Measure Validity 
Muscle strength kg/m2 Bohannon (1986) Dynamometry 
Lower limb function Lower limb function Binkley et al (1999) Lower extremity functional 
scale 
3.11 PROCEDURE 
Dynamometer was used to measure lower limb muscle strength. The dynamometer tests 
consisted of isometric "make contractions" in which the patients was to use each tested 
muscle group to push maximally against the plate and the piston of the hand-held 
dynamometer for four to five seconds. A commercially available hand-held dynamometer 
was used for testing. The tester would manually stabilize the body parts proximal to the 
tested limb segment during testing. Before testing each muscle group, the tester 
demonstrated to the patient the muscle contraction to be performed. Retests of specific 
muscle groups were performed 10 to 15 minutes after the initial test. During testing, the 
tester would keep the dynamometer scale turned from view to remain blind to the score. 
The participant would then hold the maximal contraction for four to six seconds, and then 
relax. The scale was read, and the score recorded to the nearest kilogram. The piston of 
the dynamometer was always held perpendicular to the limb segment towards which it was 
directed, and the plate of the dynamometer was always placed in the same position on the 
tested limb (Table 3.2)(Appendix H). 
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Table 3.2: Specific Patient Limb Positions (Bohannon 1986) 
Muscle Patient Limb Manually 
Group Position Positions Stabilized Dynamometer Placement Part 
Ankle Hip and knee Lower limb Just proximal to the plantar Supine 
extended proximal to metatarsophalangeal joints flexors ankle on plantar surface of foot 
Ankle Hip and knee Lower limb Just proximal to 
dorsiflexors Supine extended proximal to metatarsophalangeal joints 
ankle on dorsal surface of foot 
Knee Sitting on Knee and hip Just proximal to ankle flexed at 90 Thigh on flexors high chair degrees posterior surface of leg 
Knee Knee and hip Just proximal to ankle Sitting flexed at 90 Thigh on 
extensors degrees anterior surface of leg 
Hip flexed to Just proximal to knee Hip flexors Supine 90 degrees, Trunk on 
knee relaxed extensor surface of thigh 
Hip Hip flexed to Just proximal to knee Supine 90 degrees, Trunk on 
extensors knee relaxed flexor surface of thigh 
Knee Contra lateral Hip Supine extended, hip lower Just proximal to knee on 
abductors in neutral 
extremity lateral surface of thigh 
abduction 
Knee Contra lateral Hip Supine extended, hip lower Just proximal to knee on 
abductors in neutral 
extremity medial surface of thigh 
abduction 
1. The Lower Extremity Functional Scale - (Appendix I) was used to determine lower 11mb 
function. The Lower Extremity Functional Scale was researcher administered, that is, 
researcher would ask each participant the questions in the LEFS. Questions were 
explained to the participants until they understood what was expected for the study. The 
following is a sample question from the questionnaire. 
"We are interested in knowing whether you are having any difficulty at all with the 
activities listed below because of your lower limb function(s). Please provide an answer 
for each activity. Today, do you or would you have any difficulty with: 
(Circle one number on each line that corresponds to your appropriate answer)." 
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3.12 STATISTICAL ANALYSIS 
Muscle strength data was reduced using frequencies and percentages to draw proportional 
bar graphs. The strength of muscles of patients who were HIV positive on HAART was 
compared with HIV negative people using an independent t test. Univariate logistic 
regression was used to analyze demographic data. The relationship between lower limb 
muscle strength and lower limb function in HIV positive patients was analyzed using 
multiple regression (testing for association or independence). The p value was set at <0.05 
for significance. For each objective the type of analysis is shown in Table 3.3 
Table 3.3: Statistical Analysis 
Objective Statistical tests 
4.1 To establish lower limb muscle strength in Mean muscle strength and standard 
_patients who are HIV positive on HAART deviation. 
4.2 To establish lower limb muscle strength in Mean muscle strength and standard 
HIV ne_gative people deviation. 
4.3 To compare lower muscle strength between 
patients who are HIV positive on HAART t-test for two independent samples. 
and HIV negative people. 
4.4 To establish lower limb function in patients Frequencies and bar graphs. 
who are HIV positive on HAART Chi-square 
4.5 To establish the relationship between lower Multiple regression limb muscle strength and lower limb function 
in patients who are HIV positive on HAART Spearman's rho correlation. 
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CHAPTER 4 
4. RESULTS 
4.1 INTRODUCTION 
In this chapter the results of the data collected will be presented and analyzed according to 
the study objectives. The aim of the study was to establish the relationship between lower 
limb muscle strength and lower limb function in HIV positive patients on Highly Active 
Antiretroviral Therapy (HAART).The first objective in the study sought to establish lower 
limb muscle strength in patients who are HIV positive on HAART. The second objective 
was to determine lower limb muscle strength in HIV negative patients. The third objective 
was to compare lower limb muscle strength between patients who are HIV positive on 
HAART and HIV negative people. The fourth objective was to establish lower limb function 
in patients who are HIV positive on HAART. Objective five was to establish the relationship 
between lower limb muscle strength and lower limb function in patients who are HIV 
positive and on HAART. 
4.2 PILOT STUDY RESULTS 
The purpose of the pilot study was to establish the feasibility of using the hand held 
dynamometer and techniques for the main study. We used a total of thirteen patients which 
represents 10% of our study population to determine intra-rater reliability (Tables 4.1 a, 4.1 b 
and 4.1 c). 
Intra-rater reliability was determined by taking the same measurement three times on the 
same person on hip flexors, knee extensors and ankle dorsiflexors. Inter-rater reliability was 
ensured by getting the same reading between raters. 
Tables 4.1 a, 4.1 band 4.1 c show the results of reliability measurements with correlation 
coefficient results using Pearson's 2 tailed t-test for hip flexors, knee extensors and ankle 
dorsiflexors for 13 of the 30 pilot study subjects. 
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Table4.1a: Hip Flexor Measurements at 3 Points and Correlation between Measurements 
Hip Flexors 
Participant M*1 M*2 M*3 r-value 
O.94(M1&M) 
1 18 18 17 
2 20 21 20 
3 17 17 17 
4 20 21 21 O.95(M1& M3) 
5 14 14 15 
6 19 19 19 
7 18 16 17 O.97(M2 &M3) 
8 22 22 21 
9 15 15 15 
10 16 15 16 
11 17 17 17 
12 21 20 20 
13 16 17 17 
M*= measurements. 
Correlation is significant at the 0.01 level (2-tailed). 
Table4.1 b: Knee Extensor Measurements at 3 Points and Correlation between 
Measurements 
Hip Flexors 
Participant M*1 M*2 M*3 r-value 
1 13 14 13 O.83(M1 & M2) 
2 14 14 14 
3 15 17 16 
4 12 12 12 
5 13 12 12 
6 14 13 13 
7 12 12 13 O.90(M1 & M3) 
8 16 17 15 
9 14 13 13 
10 13 13 13 
11 12 13 12 
12 17 16 17 O.86(M2 & M3) 
13 14 13 14 0.86 
25 
Correlation is significant at the 0.01 level (2-tailed). 
Table4.1c: Ankle Dorsiflexors Measurements at 3 Points and Correlation between 
Measurements 
Hip Flexors 
Participant M*1 M*2 M*3 r-value 
1 11 10 9 O.89(M1 & M2) 
2 14 14 12 
3 12 11 11 
4 13 12 12 
5 12 12 12 
6 11 11 11 
7 9 10 10 O.76(M1 & M3) 
8 14 14 14 
9 9 9 10 
10 12 11 13 
11 13 13 12 
12 14 14 14 O.82(M2 & M3) 
13 9 11 11 
Correlation is significant at the 0.01 level (2-tailed). 
A high correlation coefficient (p-value= 0.01) using Pearson's test was established 
indicating good reliability. 
This therefore indicates that the main study measurements were going to be reliable. 
4.3 MAIN STUDY RESULTS 
4.3.1 Introduction 
The main study was conducted during the period June to September 2013.Systematic 
random sampling was used where every third patient who met our inclusion criteria was 
measured their lower limb muscle strength and functional status as they came into the 
clinic. The study sought to recruit both genders, Males (n=57) and females (n=56) were 
measured. 
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The results will be presented under the following headings: 
Description of the study participants. 
i. Lower limb muscle strength in HIV positive subjects on HAART. 
ii. Lower limb muscle strength in HIV negative subjects. 
iii. Comparison of lower limb muscle strength between HIV positive subjects on HAART 
and HIV negative subjects. 
iv. Lower limb function in subjects who are HIV positive on HAART. 
v. Relationship between lower limb muscle strength and lower limb function in patients 
who are HIV positive on HAART. 
4.3.2 Description of the Study Participants 
Demographic information of study partiCipants 
Table 4.2a and 42b describes demographic characteristic of our study participants. 
Table 4.2a: Participants' Demographic Characteristics (n=143) 
HIV Negative Group HIV Positive Group 
Demographic Characteristic (n = 30) (n=113) 
N % n % 
Gender 
Females 13 43.33 56 49.56 
Males 17 56.65 57 50.44 
Age (Years) 
15-39 24 80.00 34 30.09 
40-69 6 20.00 79 69.91 
Total 30 100.00 113 100.00 
.. The above results show 70% (n=79) of HIV positive patients on HAART In the age band 40-69 
years, whereas 80% of HIV negative subjects were below 40 years. 
Table4 .2b: Participants' Demographic Characteristics In=143)1 continue21 
HIV Negative Group HIV Positive Group 
Demographic Characteristic (n = 30t 1n = 1131 
N % n % 
Employment Status 
Employed 24.00 80.00 73.00 64.60 
Unemployed 6.00 20.00 29.00 25.66 
Retired 0.00 0.00 11.00 9.73 
Gross Monthly Income 
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<R500 6.00 20.00 36.00 31.86 
R501-R1000 1.00 3.33 14.00 12.39 
R 100 1-R2000 3.00 10.00 28.00 24.78 
R2001-R5001 17.00 56.67 33.00 29.20 
>R5000 3.00 10.00 2.00 1.77 
Housing Environment 
Share a Space/Shack 0.00 0.00 24.00 21.24 
RDP 
House/Hostel/Flat 11.00 36.67 20.00 17.70 
Town/Residential 18.00 60.00 34.00 30.09 
Rural 1.00 3.33 35.00 30.97 
Transport Means 
Walking 18.00 60.00 89.00 78.76 
Wheeled Transport 12.00 40.00 24.00 21.24 
HIV positive subjects on HAART 51% (n=73) are employed earning a salary of R2001-
R5000. 
The relationship between demographic factors within their categories and functional status 
in HIV positive people on HAART was tested using univariate logistic regression analysis 
(Table 4.2c) 
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Table 4.2c: Relationship of Demographic Factor Category to Functional Status 
(n=113) 
Demographic Mean Odds 95% Category Functional Confidence R-Value P-Value Factor Score Ratio Interval 
Males 75.39 1.05 (1.01-1.09) 0.24 0.01 
Gender 
Females 69.68 0.95 (0.92-0.99) 0.24 0.01 
Age All Ages (18-70 yrs) 72.56 N/A (63.40-81.37 0.00 0.97 
Employed 75.53 1.09 (1.04-1.14) N/A 0.00 
Employment Retired 74.25 1.07 (0.99-1.15) N/A 0.00 
Status Unemployed 62.57 0.07 0.72-1.05 N/A 0.00 
Students 71.00 1.04 (096-1.12) N/A 0.00 
<R500 52.17 N/A 0.92-1.03 N/A 1.89 
R501-R1000 77.06 N/A 0.94-1.06 N/A 1.72 
Gross Monthly R 100 1-R2000 74.10 N/A 0.98-1.08 N/A 1.69 
Income R2001-R5001 16.19 N/A 0.92-1.04 N/A 1.78 
>R5000 80.00 N/A 1.05-1.12 N/A 1.36 
Students 71.00 N/A 0.97-1.03 N/A 1.58 
Rural 53.43 0.92 0.95-1.02 N/A 0.23 
Housing Share a Space/Shack 72.67 1.00 0.96-1.04 N/A 0.23 
Environment Town/Residential 73.11 1.02 0.97-1.06 N/A 0.23 
Hostel 80.00 1.01 1.05-1.15 N/A 0.23 
Walking 66.86 0.92 (0.88-0.97) 0.12 0.07 
Transportation 
Wheeled Transport 76.19 1.09 1.04-1.14) 0.12 0.00 
Male participants were found to be functionally better than females. Employed people were 
functionally better than the unemployed. Gross monthly incomes had no effect on function. 
Participants who walked as a means of transport had a better functional score than those 
who used wheeled transport. Participants who had town/residential housing environment 
had better functional score than the other housing environments. 
4.3.3 Lower Limb Muscle Strength in HIV Positive Participants on HAART 
The lower limb muscle strength in participants who are HIV positive on HAART are 
presented in Table 4.3 
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Table 4.3: Lower Limb Muscle Strength in HIV Positive Participants on HAART 
(n=113) 
Muscle Strength kg/m2 
Muscle Group Whole Group HIV Positive Males HIV Positive Females 
Mean SO Mean SO Mean SO 
Ankle Plantar Flexors 12.46 2.79 13.7 2.64 11.21 2.37 
Ankle Dorsiflexors 9.33 2.51 10.07 2.38 8.62 2.55 
Knee Flexors 11.81 3.63 13.2 3.62 10.27 3.02 
Knee Extensors 15.36 5.4 17.64 5.3 12.64 4.04 
Hip Flexors 11.24 3.58 13.09 3.04 9.38 3.3 
Hip Extensors 15.79 5.07 18.39 4.56 13.11 4.16 
Hip Abductors 11.51 3.12 12.88 2.77 10.11 2.85 
Hip Adductors 11.09 3.64 13.54 8.8 9.43 2.99 
Hip extensors are the strongest muscle group in HIV positive subjects on HAART, while 
ankle dorsiflexors are the weakest group. This phenomenon is also true in males who are 
HIV positive on HAART. 
Tables 4.4a and 4.4b outline age specific muscle strength in HIV positive males (n=57). 
Table 4.4a: Age Specific HIV Positive Males' Muscle Strength (n=57) 
AGE BANO 
15-19 20-24 25-29 30-34 35-39 
Muscle Group 
Muscle Strength kg/m 2 
Mean SO Mean SO Mean SO Mean SO Mean SO 
Ankle Plantar Flexors 13.80 1.13 13.82 1.39 13/15 0.49 13.22 3.27 12.91 1.27 
Ankle Dorsiflexors 9.85 0.49 10.85 0.79 10.30 0.00 9.38 2.36 9.57 2.26 
Knee Flexors 15.10 1.27 13.20 2.73 16.30 0.71 12.71 3.83 12.37 3.40 
Knee Extensors 20.00 0.00 16.95 1.99 21.00 0.00 17.34 4.91 15.45 3.10 
Hip Flexors 12.65 1.06 13.85 2.18 13.40 1.13 12.07 2.67 12.95 3.32 
Hip Extensors 13.90 0.42 16.97 2.80 18.00 0.85 18.88 4.55 14.40 2.60 
Hip Abductors 13.30 1.27 13.30 2.08 13.70 1.27 13.14 1.74 11.30 3.21 
Hip Adductors 13.20 1.98 13.38 0.91 12.40 0.85 14.34 3.03 10.78 1.73 
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Table 4.4b: Age Specific HIV Positive Males' Muscle Strength (n=57) (Continued) 
AGE BANO 
40-44 45-49 50-54 55-59 60-64 65-69 
Muscle Group 
Muscle Strength kg/m 2 
Mean SO Mean SO Mean SO Mean SO Mean SO Mean SO 
Ankle Plantar Flexors 12.80 4.54 13.89 2.60 14.13 2.03 13.85 1.58 14.84 2.63 12.87 2.40 
Ankle Dorsiflexors 9.77 3.96 9.72 1.69 10.76 1.94 10.54 2.48 9.97 2.59 9.53 1.73 
Knee Flexors 11.84 4.13 11.69 3.28 15.08 4.03 16.14 3.04 12.22 2,77 13.24 3.37 
Knee Extensors 16.71 7.16 16.34 6.09 19.74 4.42 17.95 7.08 19.81 5.59 16.53 3.99 
Hip Flexors 9.80 3.48 13.56 2.85 14.74 2.67 13.29 2.93 14.16 2.95 12.14 2.22 
Hip Extensors 16.86 5.40 16.89 3.19 18.64 2.67 21.83 7.14 21.78 4.85 17.08 2.44 
Hip Abductors 10.59 3.65 12.80 2.62 13.12 2.15 13.66 2.07 14.72 3.67 11.90 1.69 
Hip Adductors 10.02 3.95 13.12 3.42 12.73 2.37 12.07 2.35 15.59 5.30 11.30 1.59 
The age band 20-25 years has the lowest mean muscle strength. 
Tables 4.5a and 4.5b outline age specific muscle strength in HIV positive females (n=56). 
Because of the number of the age bands, the tables are split into two. 
Table 4.5a: Age (Group 15-39 Years) Specific HIV Positive Females' Muscle 
Strength (n=56) 
AGE BANO 
15-19 20-24 25-29 30-34 35-39 
Muscle Group 
Muscle Strength kg/m 2 
Mean SO Mean SO Mean SO Mean SO Mean SO 
Ankle Plantar Flexors 8.50 0.71 12.04 2.26 10.92 3.66 11.53 2.15 12.13 1.97 
Ankle Dorsiflexors 7.25 1.77 8.80 1.56 8.10 1.69 8.56 2.81 9.02 3.34 
Knee Flexors 8.00 2.21 10.63 2.82 9.10 3.51 10.88 3.20 11.14 2.98 
Knee Extensors 13.50 1.41 13.68 4.47 9.40 1.65 13.00 4.17 13.50 3.52 
Hip Flexors 3.75 0.35 9.98 3.11 9.40 2.57 8.96 2.78 9.99 3.01 
Hip Extensors 20.00 5.66 12.95 4.13 9.82 2.34 13.81 5.77 14.65 4.07 
Hip Abductors 12.75 3.18 9.92 4.01 8.05 1.33 10.97 5.55 11.06 2.41 
Hip Adductors 7.75 0.35 10.84 3.77 7.70 1.81 9.66 2.99 9.76 2.82 
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Table 4.5b: Age (Group 40-64 Years) Specific HIV Positive Females' Muscle 
Strength (n=56) (Continued) 
AGE BANO 
40-44 45-49 50-54 55-59 60-64 
Muscle Group 
Muscle Strength kg/m 2 
Mean SO Mean SO Mean SO Mean SO Mean SO 
Ankle Plantar Flexors 11.15 1.95 11.92 0.80 9.79 2.67 9.00 3.56 9.52 2.48 
Ankle Dorsiflexors 9.20 2.03 9.17 2.14 9.34 2.35 7.30 3.07 4.00 2.12 
Knee Flexors 10.70 2.18 10.08 3.07 9.84 2.88 7.00 1.14 2.78 0.04 
Knee Extensors 13.32 3.60 12.25 5.97 12.80 3.24 6.63 2.50 6.75 0.35 
Hip Flexors 10.37 2.28 11.25 6.81 8.57 3.08 6.50 2.97 3.75 0.35 
Hip Extensors 13.49 1.93 12.75 4.02 11.54 3.11 9.38 3.35 8.25 0.25 
Hip Abductors 10.37 1.90 9.08 1.59 9.22 1.88 8.12 3.61 4.50 0.71 
Hip Adductors 10.17 2.11 9.67 3.34 9.79 3.03 6.13 2.66 3.75 0.35 
Muscle strength is strongest in the 20-24 years age band. 
4.3.4 Lower Limb Muscle Strength in HIV Negative Participants 
The study had 30 HIV negative participants, 17 males and 13 females. Lower limb muscle 
strength (Table 4.6) in HIV negative males (n=17) was compared to HIV negative females 
(n=13). 
Table 4.6: Lower Limb Muscle Strength of HIV Negative Participants (n=30) 
Muscle Strength kg/m2 
Muscle Group Whole Group HIV Positive Males HIV Positive Females 
Mean SO Mean SO Mean SO 
Ankle Plantar Flexors 15.10 3.29 16.58 3.68 13.77 2.77 
Ankle Dorsiflexors 11.17 2.42 11.88 2.20 10.37 2.64 
Knee Flexors 12.65 2.24 13.79 3.76 11.35 2.17 
Knee Extensors 17.07 4.46 18.87 3.55 14.75 4.36 
Hip Flexors 13.05 3.88 15.34 3.57 10.07 2.62 
Hip Extensors 17.68 4.65 19.81 3.30 15.06 4.16 
Hip Abductors 16.32 4.72 18.19 4.58 14.35 4.72 
Hip Adductors 14.13 4.36 16.00 3.47 11.64 4.79 
Results in HIV negative subjects (whole group) show very strong hip muscles inclusive (hip 
flexors, extensors, abductors and adductors). In males, ankle dorsiflexors are the weakest 
while the hip extensors are the strongest. Hip muscles are overly the strongest muscle 
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group. In females ankle dorsiflexors and hip flexors are of equal strength but are the 
weakest muscle groups in the lower limb. 
Age specific muscle strength in HIV negative males (n=17) is shown in Table 4.7below. 
Table 4.7: Age Specific HIV Negative Males (n=17) Muscle Strength 
AGE BAND 
15.29 20-24 25-29 30-34 35-29 40-44 45-49 
Muscle Group 
Muscle Strength kg/m2 
Mean SO Mean SO Mean SO Mean SO Mean SO Mean SO Mean 
Ankle Plantar Flexors 13.50 0.71 15.00 1.41 15.42 3.99 16.48 3.29 18.25 1.71 21.00 1.41 21.00 
Ankle Dorsiftexors 12.50 0.71 1.00 0.00 10.58 2.23 12.60 2.42 12.75 1.50 14.50 0.71 12.00 
Knee Flexors 12.00 0.00 9.00 1.41 13.83 2.52 13.70 13.12 17.25 7.09 17.50 0.71 10.00 
Knee Extensors 20.50 0.71 13.50 0.71 18.17 2.86 21.15 3.65 20.25 1.26 18.00 2.83 13.50 
Hip Flexors 14.50 0.71 11.00 1.41 14.50 3.29 16.55 2.50 18.50 1.00 20.00 0.00 8.50 
Hip Extensors 20.00 0.00 16.50 0.71 18.65 2.74 20.75 4.13 20.75 0.96 25.00 1.41 18.00 
Hip Abductors 17.50 0.71 14.50 0.71 17.92 3.92 18.45 3.58 17.00 2.16 3.50 0.71 13.00 
Hip Adductors 17.50 0.71 9.00 0.00 16.25 2.34 16.90 3.38 18.00 1.41 18.00 2.83 9.50 
There were no male HIV negative subjects in the 50-54 Age band upwards. Most, 58% 
(n=9) subjects were in the 30-34 years and 35-39 year age bands with their mean muscle 
strength varying from 9.00 kg Im2to 30.50 kg/m 2 . 
Age specific muscle strength in HIV negative females (n=13) is depicted in Table 4.8 below. 
Table 4.8: HIV Negative Females (n=13) Age Specific Muscle Strength 
AGE BAND 
15.19 20-24 25-29 30-34 35-39 40-44 45-49 
Muscle Group 
Muscle Strength kg/m2 
Mean SO Mean SO Mean SO Mean SO Mean SO Mean SO Mean 
Ankle Plantar Flexors 16.00 1.14 16.17 2.56 12.08 3.14 13.50 1.29 14.00 2.83 11.50 1.68 14.25 
Ankle Dorsiftexors 12.00 0.00 13.67 2.16 10.83 1.17 9.00 0.82 9.50 0.71 7.50 0.58 6.75 
Knee Flexors 9.00 1.14 13.83 1.72 9.83 0.75 10.63 0.48 12.00 0.00 10.60 10.87 13.00 
Knee Extensors 15.00 0.00 20.83 5.04 11.17 1.17 13.25 0.50 13.50 2.12 12.88 1.93 15.00 
Hip Flexors 11.00 1.14 13.67 3.01 9.17 1.92 9.50 0.50 12.50 2.12 8.88 1.95 10.50 
Hip Extensors 17.00 1.14 19.33 4.76 13.42 2.50 9.75 0,96 15.00 1.41 14.75 1.44 16.50 
Hip Abductors 14.50 0.71 20.00 4.73 10.83 3.31 11.50 1.29 17.00 1.41 13.12 4.95 13.25 
Hip Adductors 9.00 0.00 18.67 4.84 8.25 1.08 9.25 0.96 12.90 0.71 8.75 1.90 13.00 
SO 
5.60 
0.00 
0.00 
2.10 
0.70 
0.70 
0.00 
0.70 
SO 
1.70 
1.00 
0.00 
0.00 
0.70 
4.95 
0.35 
0.00 
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Females over the age of 25 were 69% (n=9) and thus in the majority. Lower limb muscle 
strength for the females ranged from 6.50kgs/m2 to 19.30kgs/m2 
4.3.5 Results of Lower Limb Muscle Strength for HIV Positive Subjects on HAART 
Compared with HIV Negative Subjects 
Lower limb muscle strength of 30 HIV negative subjects were compared to those of 30 
matched for age and gender HIV positive subjects on HAART (Table 4.9). 
Table 4.9: Comparison of 30 HIV Negative and 30 HIV Positive Participants on 
HAART (matched groups) Lower Limb Muscle Strength 
HIV Positive HIV Negative 
Muscle Group Mean Muscle Strength Mean Muscle Strength P-Value 
(kg/m2) (kg/m2) 
Ankle plantar flexors 12.76 15.36 0.0001 
Ankle dorsiflexors 9.66 11.23 0.0001 
Knee Flexors 12.30 12.73 0.46 
Knee extensors 15.72 17.08 0.08 
Hip flexors 11.67 13.33 0.0001 
Hip extensors 15.75 17.75 0.0001 
Hip abductors 11.98 16.53 0.0001 
Hip adductors 11.71 14.11 0.0001 
Lower limb muscle strength is significantly different in all muscle groups of the matched 
groups except knee flexors and extensors with p-values of 0.46 and 0.08 respectively. 
Lower limb muscle strength of 17 HIV negative male subjects were compared to those of 
17 HIV positive male subjects on HAART.The subjects were matched for age and gender 
(Table 4.10). 
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Table 4.10: Comparison of Matched Lower Limb Muscle Strength for HIV Negative 
and HIV Positive Male Participants on HAART (n=34) 
HIV Positive HIV Negative 
Muscle Group Mean Muscle Strength Mean Muscle Strength P-Value 
(kg/m2) (kg/m21 
Ankle plantar flexors 13.31 16.58 0.001 
Ankle dorsiflexors 10.07 11.88 0.0001 
Knee Flexors 13.18 13.79 0.47 
Knee extensors 16.78 18.87 0.02 
Hip flexors 12.84 15.34 0.0001 
Hip extensors 17.22 19.81 0.0001 
Hip abductors 12.70 18.19 0.0001 
Hip adductors 12.57 16.00 0.0001 
All lower limb muscle strength in 17 HIV male negative subjects were higher than the 
matched 17 male HIV positive subjects on HAART, except knee flexors. Knee flexors are 
showing a p-value of 0.47. 
4.3.6 Results of Compared Lower Limb Muscle Strength between 17 HIV Positive Male 
Subjects on HAART and 17 HIV Negative Male Subjects by Age Bands 
Lower limb muscle strength of 17 HIV negative male subjects were compared to those of 
17 HIV positive male subjects on HAART by age bands. The subjects were of the same 
ages (Table 4.11a-c). 
Tables 4.11 a-c. Mean lower limb muscle strength for HIV negative and HIV positive male 
subjects on HAART. (n=34) 
Table 4.11a: Comparison of Male Mean Lower Limb Muscle Strength 
Muscle group HIV Positive HIV Negative Mean Muscle Strength Mean Muscle Strength P-Value (25-29) (kg/m2) Jkg/m2) 
Ankle plantar flexors 13.69 15.42 0.17 
Ankle dorsiflexors 10.07 10.58 0.53 
Knee Flexors 13.06 13.83 0.51 
Knee extensors 17.46 18.17 0.63 
Hip flexors 13.16 14.5 0.28 
Hip extensors 16.16 18.67 0.05 
Hip abductors 12.57 17.92 0.01 
Hip adductors 12.93 16.25 0.01 
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Table 4.11b: Comparison of Male Mean Lower Limb Muscle Strength (Continued) 
HIV Positive HIV Negative 
Muscle group (30-34) Mean Muscle Strength Mean Muscle Strength P-Value 
(kg/m2) (kg/m2) 
Ankle plantar flexors 12.86 16.48 0.03 
Ankle dorsiflexors 9.40 12.60 0.01 
Knee Flexors 12.30 13.70 0.40 
Knee extensors 16.11 21.15 0.01 
Hip flexors 11.68 16.55 0.01 
Hip extensors 18.66 20.75 0.32 
Hip abductors 12.86 18.45 0.01 
Hip adductors 12.56 16.90 0.01 
Table 4.11 c: Comparison of male Mean Lower Limb Muscle Strength (Continued) 
HIV Positive HIV Negative 
Muscle group (35-39) Mean Muscle Strength Mean Muscle Strength P-Value 
(kg/m2) (kg/m2) 
Ankle plantar flexors 13.38 18.25 0.01 
Ankle dorsiflexors 10.85 12.75 0.11 
Knee Flexors 14.42 17.25 0.46 
Knee extensors 16.18 20.25 0.08 
Hip flexors 15.05 18.5 0.01 
Hip extensors 15.73 20.75 0.01 
Hip abductors 13.20 17.00 0.02 
Hip adductors 11.80 18.00 0.01 
A difference is noted in hip abductors and hip adductors in age band 25-29years.ln the age 
band 30-34 years all other muscle groups are showing significant difference except knee 
flexors and hip extensors. In the age band 35-39 years there is significant difference in 
ankle plantar flexors and all hip muscle groups. There is no significant difference in ankle 
dorsiflexors, knee flexors and knee extensors. 
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Compared Lower Limb Muscle Strength between 13 HIV Positive Female Subjects on 
HAART and 13 HIV Negative Female Subjects 
Lower limb muscle strength of 13 HIV negative female subjects was compared to those of 
13 HIV positive female subjects on HAART (Table 4.12). 
Table 4.12: Mean Lower Limb Muscle Strength for HIV Negative and HIV Positive 
Female Subjects on HAART (n=26) 
HIV Positive HIV Negative 
Muscle Group Muscle Strength 
(kg/m2) (n=13) 
Muscle Strength 
(kg/m2) (n=13 ) 
P-Value 
Ankle plantar flexors 12.04 13.77 0.03 
Ankle dorsiflexors 9.13 10.37 0.05 
Knee Flexors 11.13 11.35 0.75 
Knee extensors 14.34 14.75 0.72 
Hip flexors 10.13 10.71 0.45 
Hip extensors 13.83 15.06 0.28 
Hip abductors 11.04 14.35 0.01 
Hip adductors 10.58 11.63 0.35 
There is significant difference in muscle strength between ankle plantar flexors, ankle 
dorsiflexors, hip flexors and hip abductors. There is no significant difference in knee flexors, 
knee extensors, hip extensors and hip adductors. 
Results of compared lower limb muscle strength between 13 HIV positive female 
subjects on HAART and 13 HIV negative female subjects by age bands 
The Lower limb muscle strength of 13 HIV negative female subjects were compared to 
those of 13 HIV positive female subjects on HAART by age bands (Table 4.13 a-d). 
4.13 a-d Shows the mean lower limb muscle strength for HIV negative and HIV positive 
female Table subjects on HAART by age band (n=26). 
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Table 4.13a: Comparison of Lower Limb Muscle Strength by Age Bands 
HIV Positive Female HIV Negative Female 
Muscle Group (20-24) Mean Muscle Strength Mean Muscle Strength P-Value 
(kg/m2) (n=13) (kg/m2) (n=13) 
Ankle plantar flexors 11.7 16.17 0.01 
Ankle dorsiflexors 8.78 13.67 0.0001 
Knee Flexors 10.96 11.35 0.68 
Knee extensors 14.85 19.38 0.05 
Hip flexors 9.08 13.67 0.03 
Hip extensors 14.53 19.33 0.09 
Hip abductors 10.08 20.00 0.0001 
Hip adductors 9.55 18.67 0.0001 
Table 4.13b: Comparison of Lower Limb Muscle Strength by Age Bands (Continued) 
HIV Positive Female HIV Negative Female 
Muscle group (25-29) Mean Muscle Strength Mean Muscle Strength P-Value 
(kg/m2) (n=13) (kg/m2) (n=13) 
Ankle plantar flexors 11.70 16.17 0.01 
Ankle dorsiflexors 8.78 13.67 0.0001 
Knee Flexors 10.96 11.35 0.68 
Knee extensors 14.85 19.38 0.05 
Hip flexors 9.08 13.67 0.03 
Hip extensors 14.53 19.33 0.09 
Hip abductors 10.08 20.00 0.0001 
Hip adductors 9.55 18.67 0.0001 
Table 4.13c: Comparison of Lower Limb Muscle Strength by Age Bands (Continued) 
HIV Positive Female HIV Negative Female 
Muscle group (30-34) Mean Muscle Strength 
(kg/m2) (n=13) 
Mean Muscle Strength P-value 
(kg/m2) (n=13) 
Ankle plantar flexors 9.13 13.25 0.0001 
Ankle dorsiflexors 7.40 9.00 0.15 
Knee Flexors 8.03 10.63 0.0001 
Knee extensors 9.68 13.25 0.0001 
Hip flexors 8.35 9.50 0.02 
Hip extensors 8.73 9.75 0.43 
Hip abductors 9.38 11.50 0.06 
Hip adductors 7.55 9.25 0.03 
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Table 4.13d: Comparison of Lower Limb Muscle Strength by Age Bands (Continued) 
HIV Positive Female HIV Negative Female 
Muscle group (45-49) Mean Muscle Strength Mean Muscle Strength P-value 
(kg/m 2) (n=13) (kg/m 2) (n=13) 
Ankle plantar flexors 12.30 11.50 0.46 
Ankle dorsiflexors 10.53 7.50 0.0001 
Knee Flexors 12.63 10.63 0.26 
Knee extensors 14.78 12.88 0.22 
Hip flexors 10.95 8.88 0.06 
Hip extensors 14.50 14.75 0.83 
Hip abductors 11.50 13.13 0.54 
Hip adductors 12.35 8.75 0.09 
The results show that in the age band 20-24 years, there is significant difference in lower 
limb muscle strength in the ankle plantar flexors, dorsiflexors, hip flexors, hip abductors and 
adductors; knee flexors, knee extensors and hip extensors show no significant difference. 
In age band 25-29 years, there is significant difference in muscle strength in knee flexors, 
knee extensors, hip flexors, hip extensors and hip adductors while there is no significant 
difference in the ankle plantar flexors, dorsiflexors and hip abductors. The 30-34 age bands 
show significant difference in ankle plantar flexors, knee flexors and extensors, hip flexors 
and adductors while there is no significant difference in the rest of the groups. There is no 
significant difference in muscle strength all muscle groups except ankle dorsiflexors in the 
45-49 years age band. 
4.3.7 Results of Lower Limb Function in HIV Positive Subject son HAART 
Lower limb functional scores are shown in graphs below. 
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Figure 4.1: Lower Limb Function in HIV Positive Subjects on HAART (n=113) 
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The majority 78% (n= 88) had no difficulty, 15% (n =17) had a little bit of difficulty, 5% (n=6) 
had difficulty and only 2% (n=2) of HIV positive patients on HAART had quite a bit of 
difficulty with lower limb functional activities. 
Results of lower limb function in HIV positive male subjects on HAART 
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Figure 4.2: Lower Limb Function in HIV Positive Male Subjects on HAART (n=57) 
Just over 88% (n=50) had no difficulty with lower limb function, 11 % (n=6) had a little bit of 
difficulty while only 0.02% (n=1) had quite a bit of difficulty. Further analysis was done on 
lower limb function in HIV positive male subjects on HAART by age bands, only the age 
bands 45-49 and 50-54 had most people without difficulty. 
Results of lower limb function in HIV positive female subjects on HAART 
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Figure 4.3 Lower Limb Function in HIV Positive Female Subjects on HAART (n=56) 
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The results show that 68%( n=38) had no difficulty with lower limb function and only 2%( 
n=1) had quite a bit of difficulty. Further analysis revealed that no age bands had high 
levels of difficulty. 
4.3.8 Relationship between Lower Limb Muscle Strength and Lower Limb Function in HIV 
Positive Patients on HAART 
Table 4.14a is multiple regression summary showing the relationship between lower limb 
muscle strength and lower limb function in HIV positive patients on HAART. 
Table 4.14a: Multiple Regression Summary 
Model R R Square Adjusted R Square Std. Error of the Estimate 
1 0.71a 0.50 0.46 8.90 
p-value= 0.00000 
There is a positive correlation (correlation coefficient r=0.71) between lower limb muscle 
strength and lower limb function in HIV positive people on HAART. The correlation 
coefficient is significant at p-value =0.00 showing a high level of significance. The 
coefficient of determination (0.50 or 50%) means that 50% of lower limb function in HIV 
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positive people on HAART is a result of lower limb muscle strength. This means other 
variables contribute to lower limb function in HIV positive people on HAART. 
A detailed logistic regression (Table 4.14b) was done for the relationship between lower 
limb muscle strength and lower limb function. Ankle plantar flexors were established to be 
the most active group of muscles in lower limb functional activities in HIV positive people on 
HAART. 
Table 4.14b: Detailed Regression Model of Lower Limb Functional Status against 
Specific Lower Limb Muscle Groups 
Unstandardized Standardized 
Model 
Regression Regression 
Coefficients Coefficients 
B Std. Error Beta 
Functional status 33.90 4.26 
Ankle plantar flexors 1.49 0.52 0.32 
Ankle dorsiflexors 1.43 0.57 0.29 
Knee Flexors 0.18 0.42 0.05 
Knee extensors -.64 0.33 -.27 
Hip flexors 0.88 0.44 0.26 
Hip extensors 0.13 0.34 0.05 
Hip abductors 0.03 0.58 0.01 
Hip adductors 0.19 0.47 0.06 
The Spearman's rho correlation was also done to establish the order in which each muscle 
group was contributing towards lower limb functional activities (Table 4.15). The 
Spearman's rho correlation coefficient confirmed the order of how much each lower limb 
muscle group is contributing to lower limb function. 
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Table 4.15: Order of Contribution of Muscle Groups to Lower Limb Function 
Independent Variable 
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~ "C 
Dependent variable 
Functional status 0.56 0.45 0.54 0.40 0.54 0.46 0.51 0.50 
Correlations ranked 1 7 2 8 3 6 4 5 
4.4 CONCLUSION 
The results established that lower limb muscle strength contributes 50% to lower limb 
function. Gender,walking, being employed and housing environment also positively 
influenced lower limb function. Ankle plantar flexors are the most active muscles when 
performing lower limb functional activities in this cohort, while knee extensors are the least 
(8th) active. Hip flexors are third in terms of activity level while hip extensors are the 6th most 
active in lower limb functional activities. 
The results suggest that hip extensors are the strongest lower limb muscles in both HIV 
positive and negative subjects. Hip extensors mean muscle strength in HIV positive people 
on HAART was 15.80kg/m2 whereas for the HIV negative people it was 17.70kg/m2 . Ankle 
dorsiflexors were the weakest lower limb muscle group in both HIV positive participants on 
HAART and HIV negative people with a mean muscle strength of 11.20 kg/m2 in HIV 
negative people and 10.1 Okg/m2 for the positive group on HAART. All Lower limb muscles' 
strength is significantly less for HIV positive people on HAART when compared to the HIV 
negative group except knee extensors with a p-value of 0.08. 
This study established that 77% (n=88) had no difficulty with lower limb function, 22% 
(n=17) had difficulty, while only 2% (n=2) having quite a bit of difficulty with functional 
activities. 
This study had equal number of HIV positive females on HAART (n=56) and males (n=57) 
as subjects. Seventy three (65%) of the HIV positive people on HAART were formally 
employed, 26% (n=29) was not employed and 10% (n=11) were retired. The majority 
(n=20) of HIV positive people on HAART were in the 45-49 year age category while the 
majority of the HIV negative (n=10) were in the 25-29 year category. Walking was the 
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dominant mode of transport used by most HIV patients on HAART 79% (n=89) even for 
urban dwellers who constituted 69% (n=78) of this study. The remainder 31 % (n=35) were 
rural dwellers. For the urban dwellers 22% (n=24) lived in shacks or shared their 
accommodation, 18% (n=20) stayed in a hostellflat or Hlalani Kuhle (RDP) housing while 
30% stayed on a residential stand. 
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CHAPTER 5 
5. DISCUSSION 
The primary aim of this study was to establish the relationship between lower limb muscle 
strength and lower limb function in HIV positive patients on HAART. 
Male and female ambulant adult HIV positive patients who were on HAART aged between 
18- 70 years were included in the study. 
Since the aim of this study was to look at the relationship between lower limb muscle 
strength and lower limb function in HIV positive patients on HAART, findings would 
contribute to understanding possible factors affecting decreased lower limb functional 
status in this population. Low cost rehabilitation intervention programmes would then be 
designed so as to be implemented at primary care level. This is because the integration of 
antiretroviral therapy into HIV care has dramatically extended the life expectancy of those 
living with HIV (Erlandson et aI., 2014). Approximately one half of the people living with HIV 
in the United States are fifty years or older (Effros et aI., 2008). With an increasing life 
expectancy in HIV infected patients (Lewden et aI., 2012), age-related changes and co-
morbidities have become a concern as they occur relatively early in this population 
(Capeau, 2011). Poor locomotor performance is highly prevalent in middle-aged ambulatory 
HIV-infected patients on HAART who had well-controlled viral load (Richert et aI., 2014). 
5.1 RELATIONSHIP BETWEEN LOWER LIMB MUSCLE STRENGTH AND LOWER LIMB 
FUNCTION IN HIV POSITIVE PATIENTS ON HAART 
The relationship between lower limb muscle strength and lower limb function in HIV positive 
cohort in Manicaland Zimbabwe was established using multiple regression. The results 
established that there is a positive correlation (correlation coefficient (r)=0.71) (p-
value=O.OO) between lower limb muscle strength and lower limb function in HIV positive 
people on HAART. The coefficient of determination (0.50 or 50.00%) means that 50% of 
lower limb function in HIV positive people on HAART is a result of lower limb muscle 
strength. Gender, being employed, housing environment and mode of transport also 
positively affected lower limb function in this cohort. 
A detailed regression model of lower limb functional status against specific lower limb 
muscle groups was done. The results showed that lower limb ankle plantar flexors 
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contribute the most to lower limb function in HIV positive people on HAART. International 
literature says hip flexors are the dominant factor in lower limb functional activities 
(Fotoohabadi et al. ,2010) 
It is imperative to look at the biomechanics of standing up from a sitting position since the 
majority of lower limb functional activities lower limb functional activities such as getting up 
from a chair and walking depend on an individual's ability to perform sit to stand. 
The activities of rising from a sitting position into standing is an essential prerequisite for 
walking and therefore, lower limb functional independence (Tiedemann et aI., 2008). It has 
been reported that people who have difficulty rising to a standing position have a greater 
likelihood of falling during ambulation (Yamada et al.,2009) and to need help with daily 
lower limb functional activities (Puthoff et aI., 2007).Coming from sitting to a standing 
position is a coordinated sagittal movement between the hips, knees, lumbar spine and 
thoracic spine in a healthy individual. Hip joint flexion is the dominant factor in bringing the 
body mass forward, and a small degree of lumbar flexion is also a component of trunk 
forward lean (Fotoohabadi et al.,201 0). 
Fotoohabadi et al (2010) did a study on kinematics of rising from a chair. They had a 
sample of convenience of 41 community-dwelling elderly people (22 female and 19 male). 
The study established that full available hip flexion (90%) was used by these participants 
during the pre-lift off phase of coming from sitting to standing. This demonstrates that hip 
flexion limitation would pose a major challenge in the kinematic chain. Possible 
compensation would include increased lumbar flexion instead of extension to bring the 
trunk sufficiently forward at an appropriate velocity (Fotoohabadi et aI., 2010). Trunk 
movement must be sufficient to propel the upper body mass forward (Riley et aI., 1991). 
This trunk movement must be limited to prevent the possibility of falling forward at the lift-off 
phase (Mourey et aI., 2000). 
The importance of postural stability around the lift-off phase of sit to stand by controlling the 
centre of mass in relation to the foot support area has been emphasized (Carr et aI., 2003). 
The above discussed sequence happens in healthy individuals. What this means is in 
healthy HIV negative population, the most active muscles during lower limb functional 
activities are the hip and trunk muscles which represent proximal stability. In the current 
study we established that in HIV positive people on HAART, ankle plantar flexors are the 
most active lower limb muscle group during lower limb functional activities. Ankle plantar 
flexors are distal musculature of the lower limb. This cohort could possibly be compensating 
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by increasing lumbar flexion or thoracic flexion instead of extension to bring the trunk 
forward to perform lower limb functional activities (Carr et aI., 2003). 
These results are showing proximal weakness which is consistent with Myezwa et aI's 
(2009) findings. Myezwa et al (2009) found that HIV affects function in general. Proximal 
weakness which compromises function is a common feature when HIV patients were tested 
using dynamometry. None of the studies reviewed that have examined lower limb muscle 
strength and lower limb function has established how much each lower limb muscle group 
contributed to lower limb function. Therefore this is the first study to the researchers' 
knowledge that has explored the relationship between lower limb muscle strength and 
lower limb function in HIV positive patients on HAART. 
5.2 LOWER LIMB MUSCLE STRENGTH 
The mean muscle strength obtained in this cohort of HIV positive patients on HAART 
ranged from 9.30kg/m2 to 15.80kg/m2 in all muscle groups tested. The muscle groups 
included were ankle plantar flexors, ankle dorsiflexors, knee flexors, knee extensors, hip 
flexors, extensors, abductors and adductors. These values were compared to an equally 
matched HIV negative group. The findings showed that in the HIV negative matched group, 
the mean muscle strength ranged from 11.20 kg/m 2 to 17.70kg/m2 for the same muscles. 
The difference between the group values had a statistically significant difference as follows: 
ankle plantar flexors (0.001), Ankle dorsiflexors (0.0001), Knee flexors (0.47), Knee 
Extensors (0.02), Hip flexors (0.0001), Hip extensors (0.0001), Hip abductors (0.0001) and 
Hip adductors (0.0001). 
Bahannon (1997) in his reference values for extremity muscle strength obtained by hand-
held dynamometry from adults aged 20 to 79 years had a similar finding among the HIV 
negative group. In Bahannon's (1997) subjects from a convenient sample of 106 men and 
125 women, who on entrance into the study were without any neuromuscular, 
musculoskeletal or cardiovascular pathology established that muscle strength ranged from 
(95.90N) 9.80kg/m2 in dorsiflexors to (218.40N) 22.30 kg/m 2 in hip abductors in female 
subjects. No reading for hip extensors was given in this study. 
This study's results show that lower limb mean muscle strength for matched HIV negative 
group was significantly greater (p-value= 0.0001) than that of the HIV positive group on 
HAART except knee flexors and knee extensors whose p values were 0.46 and 0.08 
respectively. This is consistent with Mascolin (2011) finding in HIV positive people in a 
French Acquaintance cohort, where he established that HIV positive people had poor leg 
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muscle strength when compared to the general population. Sagui (2005) also established 
that lower limb muscle weakness was a common complaint among HIV positive patients on 
HAART presenting to family physicians. 
In contrast Kinsey (2007) reported that there was no significant difference (p-value=0.78) 
between HIV positive females on HAART for seven months and their HIV negative 
counterparts. In the current study sample, patients had been on HAART for an average of 
four years while Mascolin (2011) and Sagui (2005)'s samples had been on HAART for an 
average of three to five years. There is a difference between Kinsey's (2007) findings that 
there was no difference in lower limb strength in HIV positive females on HAART for seven 
months and our finding that there is a significant difference. This disparity is explained by 
Carter et ai's (2011) study showing that each year of infection with HIV increases the risk of 
poor lower limb strength by 8.00%. Lower limb muscle weakness in HIV positive people on 
HAART is a result of mitochondrial toxicity (Kohles et aI., 2007), limited extraction! use of 
oxygen in the lower limb musculature (Menders et aI., 2013; Mascolini, 2011). Guazzi 
(2000) suggested that there were structural changes to capillaries in lower limb muscles 
leading to "stress failure" of the capillary membranes. This "stress-failure" of the capillary 
membranes in lower limb muscles progresses to thickening of the capillary enterstium and 
increased permeability of water and ions. There is a consequent disruption of local 
regulatory mechanism for gaseous exchange leading to lower limb muscle fatigue 
secondary to diminished oxygen availability and poor cell regeneration leading to cachexia 
(Guazzi,2000). 
Furthermore, another mechanism that affects muscle function is explained by Russ et al 
(2010) that contractile properties of knee extensors indicated potential intra-muscular 
impairments. Gene expression analysis in the muscle tissue of HIV-infected patients 
suggests alterations similar to those observed with aging (Kusko et aI., 2012). There is a 
resultant impairment of locomotor function, deterioration of lower limb functional ability and 
limitations in activities of daily living (Richert et al.,2011). 
5.3 LOWER LIMB FUNCTION 
The international classification of function, defines function as what a person with a healthy 
condition can do in a standard environment (their level of capacity) as well as what they 
actually do in their usual environment (their level of performance) (WHO,2002). Functioning 
refers to all body functions, activities and participation including environmental factors that 
interact with all these components (WHO, 2002). 
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The lower extremity functional scale (LEFS) which was used to measure lower limb function 
in this study established that the majority (78%), n=88) had no difficulty with lower limb 
function, 22% (n=17) had difficulty. Only 2% (n=2) of HIV positive patients on HAART had 
quite a bit of difficulty with lower limb functional activities. This is a total 24% experienced 
functional difficulty similar to Oursler et al (2009) who found that lower limb function is 
preserved in almost 90% of HIV positive people on HAART. In a study by Van As et al 
(2008) they found that there is loss of lower limb functional capacity in this group 
consequently affecting their Health Related Quality of Life (HRQOL). 
Loss of lower limb functional activities in HIV positive people on HAART could be explained 
by the disablement model originally conceptualized by Nagi et al (1964) and extended by 
Verbrugge et al (1994). They linked pathology, physical impairment, functional limitation 
and disability (Nagi et aI., 1964; Verbrugge et aI., 1994). According to this model, an 
underlying pathology, in this case mitochondrial toxicity, limited extraction/use of oxygen in 
the lower limb musculature or "stress failure" of capillary membranes will lead to 
"impairment" at the tissue, organ or body system level (Erlandson et aI., 2014). The 
"impairment" in our current study is loss of lower limb muscle strength. This impairment 
results in "functional limitation" which could be slow gait speed or difficulty rising from a 
chair (Puthoff et aI., 2007). Ultimately disability sets in, in which the patient is eventually 
confined to a wheelchair (Erlandson et aI., 2014). 
One of the strengths of this study was the equal representation of the genders 50% (n=56) 
females and 50% (n=57) males. This is unlike other studies that have studied HIV 
populations. An example is the study done by Raso et al (2013) on Handgrip Force after a 
measure of physical function in individuals living with HIV/AIDS. Their sample consisted of 
40 carefully screened male patients recruited from an ambulatory outpatient HIV/AIDS 
clinic. Roos et al (2014), however, in the study "not easy at all but I am trying": barriers and 
facilitators to physical activity in a South African cohort of people living with HIV 
participating in a home-based pedometer walking program had a closer representation of 
males and females. 
The study setting Mutare Provincial Hospital is a public hospital situated in the Eastern part 
of Zimbabwe serving a population of 1.20 million people. The participants' age ranged 
between 18 and 70 years. Over nine percent (n=22) of HIV positive participants on HAART 
were in the age band 45-49 years, close to six percent (n=7) was between 65 and 69 years. 
This demographic data is consistent with other studies on HIV that HIV positive people on 
HAART are aging (Hanass-Hancock et aI., 2003, Cade et aI., 2003, Hunter et aI., 2004). 
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Erlandson et al (2014) noted that the integration of HAART into HIV care has dramatically 
extended the life expectancy of those living with HIV. 
Approximately one half of the people living with HIVIAIDS on HAART are not only 
concerned with a treatment's ability to extend life but also with the quality of life they are 
able to lead (Gale, 2003). The health related quality of life (which includes the ability of an 
individual to function) of people living with HIV/AIDS in South Africa and elsewhere has 
been found to be severely compromised (Myezwa et aI., 2011). The need for designing 
rehabilitation strategies to improve lower limb muscle strength and consequently function is 
thus further justified by this study. In any case; physiotherapy is a profession providing 
services to people and populations to develop, maintain and restore maximum movement 
and functional ability throughout their life span (Kumar, 2010). 
Pebody (2009) found that with improved treatments, a majority of the people living with HIV 
are able to remain in employment. This is consistent with our finding where we found 65% 
(n=73) was gainfully employed while 26% (n=29) was not employed and over nine percent 
(n=11) was retired. Pebody's (2009) findings only related to gays and bisexual men living 
with HIV in the United Kingdom. Our study population shows that HIV positive people on 
HAART are gainfully employed with some reaching retirement. 
The majority of our study participants 79% (n=89) walked as their mode of transport. They 
walked because they could not afford the transport cost which on average was R10.00 
(approximately one United States dollar). Most participants would walk in order to save their 
earnings for essentials like food, nutrition and school fees for their children. Wheeled 
transport was used by 21% (n=24) of the study population. The wheeled transport was 
primarily buses and taxis. 
Brisk walking or jogging to a threshold of 24 to 32 kilometers per week results in an energy 
expenditure of 1200 to 2200 kilocalories per week. It improves function and is beneficial to 
healthy living (Durstine et aI., 2001). It is possible that the respondents in this study were 
engaging in brisk walking which met the beneficial threshold. Roos et al (2014) clearly 
states that prescription guidelines do not influence adherence to physical activity 
programmes but personality, social and environmental factors played a larger role. This can 
possibly explain the high functional status which was observed in this study; the social and 
environmental factors were influencing our study participants to engage in lots of walking. 
We established that 78% (n=88) of HIV positive subjects on HAART had no difficulty with 
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lower limb functional activities while only 2% (n=2) had quite a bit of difficulty. The majority 
of the participants 79% (n=89) walked as their mode of transport. 
Lower limb muscle strength was responsible for 50% of lower limb function in our study 
participants while gender, being employed, housing environment and mode of transport 
also positively influenced lower limb function. The most active lower limb muscle group was 
ankle plantar flexors meaning HIV+ people on HAART would compensate proximal muscle 
weakness during lower limb functional activities. There is proximal weakness in this cohort. 
Lower limb muscle strength was significantly less in HIV positive people on HAART when 
compared to the negative group. A total of 24% had difficulty with lower limb function. 
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CHAPTER 6 
6. CONCLUSION, LIMITATION AND RECOMMENDATIONS 
6.1 CONCLUSION 
This study was beneficial in highlighting that 50.00% of lower limb function is a result of 
lower limb muscle strength in HIV positive people on HAART attending an outpatient clinic 
in Mutare, Zimbabwe. Walking, employment and housing environment also contributed 
positively to this cohort's lower limb function. 
This project highlighted that ankle plantar flexors were the most active muscle group during 
lower limb functional activities. Literature on lower limb function indicates that hip flexors 
are the most active muscle group during lower limb functional activities (Fotoohabadi et aL, 
2010). It therefore means exercise prescription to activate/strengthen hip flexors and other 
proximal muscles will benefit this population since exercises have been proved to 
strengthen muscles (O'Brien et aL, 2004). 
International literature suggests that HIV positive people on HAART have lower limb muscle 
strength compared to their HIV negative counterparts (Mascolin, 2011; Sagui, 2005). The 
current study confirmed that lower limb muscle weakness is prevalent in HIV positive 
people on HAART. Most participants in this study were walking as their main mode of 
transport and walking is a recommended exercise regime (Roos et aL, 2014). They 
reported walking long distances which could be more than 10000 steps per day because of 
their social and environment factors. This walking could be responsible for why a large 
number of these HIV positive people on HAART 78% (n=88) had no difficulty with lower 
limb function. 
The study contributes to literature related to HIV and function in individuals who are HIV 
positive on HAART. 
6.2 LIMITATIONS 
The research project was done in Zimbabwe while the country was undergoing a 
challenging economic situation. The study setting made the study difficult to implement as 
the participants were experiencing a difficult socio-economic situation such that participants 
were walking long distances and would be tired or hungry during measurements. We could 
have controlled this by giving them a snack but the researcher failed to obtain funding to do 
52 
so. This possibly negatively affected our results in that we would get reduced lower limb 
muscle strength. 
6.3 RECOMMENDATION 
The research project highlighted several areas where research is needed. 
• The study highlighted that participants found the muscle testing and lower limb 
functional scoring beneficial. Muscle testing and lower limb functional scoring in current 
HAART management and prescribing strengthening exercises could be beneficial. 
• The project focused on assessing lower limb muscle strength and lower limb function 
on people living with HIV/AIDS on HAART at an outpatient clinic. Research is needed in 
newly' diagnosed on HAART and HIV+. 
• Research could be carried out to see how Zimbabweans who are HIV positive on 
HAART perceive documented exercise interventions which are known to be beneficial. 
• Research could be conducted to ascertain how much walking or physical activity level 
of HIV positive patients on HAART undertake on a daily basis and encourage this low-
cost beneficial exercise programme. 
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Telephonc:.263-020-64321 
Fax: +;163-020-<;1048 
£..mail: ~~~n~s.ll:.D:~. 
~,.lr Peter ,,'hari~a 
S PCI1h Cird~ 
\\'",!iea 
'H'TARE 
Reference: 
MINISTRY Of HEALTH & CHIlD·WElFARE 
Mutafe ProvlncliJl HCOpilol 
SCHOOL Of NURSING 
PO Box 30 
CLEARANCEJ'-OR MR I'l<:TER IVIHARlWA STUm<:NT NO. 5735% TO CARny (HiT 
RESl;iARCn STOhY: ~1Ul'ARE PROVI:\C1AL HOSPITAL 
P .... rm;:5'5ioI) j~ h\."n.:'1~~<~xant\-"{1 fnr the ab~)\'<~llamcd to cOllduet a :-.tudy tided 'i.Tht'- Relationship between 
10" cr limb III uscf':':~,igth rlncl){tiYl'r. her 'l' In ill H1V pllticuts 011 I Iip:hly Aclive Antirctruyil'aJ 
Therapy (fU,AI~Tr', ~ ~,;'". J .. ,,;' . 
.. 0:.< ,';:;, IAUrARE 
DR S.'I.XYAU rxue""'~~NE 
'IF,BleAt. SliPERIN '., 
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INFORMED CONSENT FORM 
INFORMED CONSENT 
I hereby confirm that I have been informed about the nature, conduct, bE:!nefits 
and risks of the above study: THE RELATiONSHIP BETWEEN LOWE~ LIMB 
MUSCLE STRENGTH AND LOWER LIMB FUNCTION IN HiV PATIEN"TS ON 
HIGHLY ACTiVE ANTIRETROVIRAL THERAPY (HAARn. I have also 
received, read and understood the above information regarding the study. 
I have had sufficient opportunity to ask questions and declare myself pre pared to 
participate in this study. 
PARTICIPANT: 
Printed name 
Date and time 
Signature/ Mark or thumbprint 
I Peter, Clever Mhariwa herewith confirm that the above participant has been 
fully informed about the nature, conduct and risks of the above study. 
RESEARCHER: 
Printed name 
Date and time 
Signature 
14 
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APPENDIX : INFORMATION SHEET 
INFORMA TION SHEET 
THE RELATIONSHIP BETWEEN LOWER LiMB MUSCLE STRENGTH AND 
LOWER LIMB FUNCTION IN HIV PATIENTS ON HIGHLY ACT!VE 
ANTIRETROVlRAL THERAPY (HAART). 
Introduction 
Good day, my name is Peter, Clever Mhariwa, I am a physiotherapist and 
currently a postgraduate student at the University of the Witwatersrand 
Johannesburg. I would like to invite you to participate in a research study titled 
THE RELATIONSHIP BETWEEN LOWER LIMB MUSCLE STRENGTH AND 
LOWER LIMB FUNCTION IN HIV PATIENTS ON HIGHLY ACTIVE 
ANTIRETROVIRAL THERAPY(HAART). Before agreeing to participate, it is 
important that you read and understand the following study, the study 
procedures, benefits and risks. If you have any questions, do not hesitate to ask. 
Purpose of Study 
The purpose of this study is to establish the relationship between muscle 
strength and lower limb function in HIV positive patients on HAART. 
Procedures 
If you agree to participate in this study your lower limb muscle strength will be 
measured by a hand held dynamometer. You will also be asked questions to 
establish your lower limb function. Measuring your muscle strength and 
establishing your lower limb functional status will take approximately 45 minutes. 
Risks and discomforts 
This study has no risks or discomforts 
Benefits and Compensation 
This study may contribute to understanding status of muscle strength and its 
relationship to lower limb function in adults with HIV infection. It will also 
contribute to designing interventions for counteracting reduction in lower limb 
function. You will not be paid to participate in this study. 
Voluntary Participation 
Participation in this stUdy is voluntary. If you decide not to participate in this 
study, your decision will not involve a penalty and you are free to withdraw at any 
time. You have the right to decline to answer questions you are not comfortable 
with. 
Confidentiality 
Efforts will be put to ensure absolute confidentiality. Your name and personal 
information will not be used in the course of this study. 
Contacts and Questions 
For further information and questions, the researcher can be reached at the 
Department of Physiotherapy, University 0 f the Witwatersrand, Johannesburg 
South Africa, tel: +27 11 7171030 or by email at petrosmhariwa@yahoo.com. 
Information on questions on ethical considerations and approval can be obtained 
from the chairman of the Human Research Ethics Committee (Medical), 
University of the Witwatersrand, Johannesburg, South Africa, Prof P.E. Cleaton-
Jones tel: +277171234, fax- +27117171265 
13 
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fh" Medkal Superintendent 
;\1utar~ Pny..'inclul llospifnl 
Mutare 
ZinlbLib\ve 
J 1 Fehruarj 2013 
l:i Perth Circ'k 
\\\:stle:1 
:VI Ula .. ..: 
Dear Sir 
Rl!::APPl.ICATION H)R pl<:Rl\nSSION TO no MY RES .. ~ARCH PRO.Jl'~CT AT 
Mt:TARE PROVINCIAL HOSPITAL. 
1 hereby app!) lor permi»sioll to carry nut rn)' research pro.icc! ttt ~luture Provincial 
I [o';l'[tal. I am :l final year "'1s~' l'hysioth"rapy student at the l'niyersity Qf \Vitwatersrand 
in South Ati'ka, My re,;earch topic is "THE RELATIONSHIP UET\VEEN LO,\VER 
u;vm MUSCLE STRF,N(;Tll ANI) LOWER LIMB FlJ!'ICTION IN HI\, 
PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAl, THl!:RAl)Y (HAART)" 
The aim \)f the research b to eSlablish tlw rdatiunship bet'",:cll lower limb muscle 
strength and lower limh fum:tion in pmiL'nt~ who al'e IIlV positive on flAART. 
Thl:: $mnph.~ ~i~J'~ \\iU h~ 137 pati\.~l1ts ~Shl) an.! g.oing ({\ be .$anlplcd using sy~ternatic 
random smuplin!;!., An equa!llumber ,,[males ",,,1 t",nuk"" will be tnrget.;:d. 
111l! prOI..:~dlln!" involves I11casuring h.n,-,\,."r ltolb rnu!-<(.;!c ~trength u:--;ing a hand heid 
dynamometer. Path::I1L~ win 'lIs,) be ask"d 'luestions It, .. ";tabli"h low" .. limb t"metlon. 
'ka<;uring a s,nge p.ui.;:ut" lower limb strength and est::<hlishing there lower limb li,II1.~tilln 
will take appm"imately 45 minutes, 
'I hi" s;tldy may contribute to umh::rSltUlding. th", stall" ofmusd" strength and its 
rcb.1.ion$blp to 10\.\C1" !i111b fUl11."tllH1 in adU!l~ \\·ith 111\/ intccHc.1n. It ,vill abo contribute to 
dt.~signln.g int<.!r\'~nth")ns 1~)1' c{.)~tntcring reJU<.~ti()1i in lO\-\'t.T lirnh t~n~tit~l\. 
This study has n\, rb<ks or Jiscnm!i.l!1s. Parlicipali,)11 ;" \o!unl"r~ and patients will be ffce 
to "\vithJnJ'" at ~Ul~ tin11t if lhl.!Y gO v, ish. 
Frtbrts will be put to ""sure "hs"lut<: ~,)nfidenlia!i\). NamL"s and per~onal inlio)nnatioll of 
pUlienls will Ilot be u:icd in the cour"", "t" this study, 
Hoping. to hear from ;.ou at earliest con\'~nk'!lee 
66 
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~fl;~ithj~'11<., 
~;'Mhar\ .... va' '~;' 
(M~c Physiotherapy SUl.<.h .. 'nt) 
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DYNAMOMETRY FOR LOWER LIMB MUSCLE STRENGTH 
Positions for Muscle Groups to be tested 
! Muscle group I Patient I Limb positions i Manually I Dynamometer 
I i position ' stabilized part ( placement 
r Ankle plantar 1 supine Hip and knee i Lower limb Just proximal to the 
flexors I extended proximal to metatarsophalangeal 
I ankle joints on plantar 
surface of foot 
Ankle Supine Hip and knee Lower limb Just proximal to the 
\ dorsiflexors extended proximal to metatarsophalangeal 
ankle joints on dorsal 
i surface of foot 
, K, •• fl.""" I ,"log Knee and hip Thigh Just proximal to I 
flexed at 90 ankle on posterior I ~ S" degrees surface of leg i --l : Knee Ittlng Knee and hip Thigh Just proximal to l extensors I flexed at 90 ankle on anterior degrees i surface of leg 
Hip flexors Supine Hip flexed to Trunk i Just proximal to 
90 degrees, I knee on extensor 
knee relaxed surface of thigh 
Hip extensors Supine Hip flexed to Trunk Just proximal to 
90 degrees, knee on flexor I 
I knee relaxed surface of thigh ! I H;p a:d'cto" Supine I K, •• Contralateral Just proximal to I extended. hip lower extremity knee on lateral 
in neutral surface of thigh 
-1 I I abduction Hip aaductors I Supine Knee Contralateral Just proximal to extended, hip I lower extremity knee on medial 
j 
I in neutral surface of thigh I I : abduction 
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• LOWER EXTREMITY FUNCTIONAL SCALE 
The Lower Extremity Functional Scale. 
We are interested in knowing whether you are having any difficulty at all with the 
activities listed below because of your lower limb problem (s). Please provide an answer 
for each activity. Today, do you or would you have any difficulty with: 
(Circle one number on each line that corresponds to your appropriate answer) 
I Activity Unable to Quite a bit Moderate A little a perform of difficulty difficulty bit k--·...- activity difficulty 1. Any of your usual work, (e.g. work that earns 0 1 2 3 
you income, or any other work you do) housework, 
or school activities 
2. Your usual hobbies, recreational or sporting 0 1 2 3 
activities, e.g. attending weddings, church or 
visiting friends 
3. Getting into or out'o'{!he bath/taking bath. 0 1 2 3 
4. Walking between rooms (such as walking 'from 0 1 2 3 
your room to toilet, bath room, kitchen, etc) 
5. Putting on any kind shoes or socks you want, 0 1 2 3 
including slippers or open shoes, if applied. 
6. Squatting (e.g. squatting on pit latrine/doing 0 1 2 3 
any squatting activity) 
7. Lifting an object, like a bag of groceries or a 0 1 2 3 
small container like 5 liters container full of water, 
basket of potatoes, etc, from floor 
.. 
8. Performing light activities around your 0 1 2 3 
home(such as prepare a meal, cleaning a house, 
making bed, or any other light activity at home) 
9. Performing heavy activities around your'home 0 1 2 3 
(digging, lifting a heavy bag of potatoes, 20 litres 
gerrican of water, shifting big items, etc 
10, Getting into or out of a car/taxi. 0 1 2 3 
11. Walking across from your home to neighbors 0 1 2 3 
or walk like 100m across 
12. Walking a Km, such as going to market, 0 1 2 3 
church or any other place where you walk 
13. Going up or down' 1 0 stairs (abo'':it1 flight of 0 1 - 2 3 
stairs) or walking up a steep and irregular ground 
- -
14. Standing for 1 hour, 0 
.--
1 2 3 
15. Sitting for 1 hour, like when in church, tax, or 0 1 2 3 
meetings 
--"-------
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--No 
difficulty 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
-
4 
4 
4 
4 
4 
---
